Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 57
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Toward online quantification of tracheal stenosis from videobronchoscopy, Towards on-line quantification of tracheal stenosis from videobronchoscopy

  • Sánchez, Carles
  • Bernal del Nozal, Jorge|||0000-0001-8493-9514
  • Sánchez, F. Javier|||0000-0002-9364-3122
  • Diez-Ferrer, Marta|||0000-0002-0207-8157
  • Rosell Gratacos, Antoni|||0000-0003-0877-7191
  • Gil, Debora|||0000-0002-2770-4767
Purpose Lack of objective measurement of tracheal obstruction degree has a negative impact on the chosen treatment prone to lead to unnecessary repeated explorations and other scanners. Accurate computation of tracheal stenosis in videobronchoscopy would constitute a breakthrough for this non-invasive technique and a reduction in operation cost for the public health service. Methods Stenosis calculation is based on the comparison of the region delimited by the lumen in an obstructed frame and the region delimited by the rst visible ring in a healthy frame. We propose a parametric strategy for the extraction of lumen and tracheal rings regions based on models of their geometry and appearance that guide a deformable model. To ensure a systematic applicability, we present a statical framework to choose optimal parametric values and a strategy to choose the frames that minimize the impact of scope optical distortion. Results Our method has been tested in 40 cases covering dierent stenosed tracheas. Experiments report a non clinically relevant 9% of discrepancy in the calculated stenotic area and a computational time allowing on-line implementation in the operating room. Conclusion Our methodology allows reliable measurements of airway narrowing in the operating room. To fully assess its clinical impact, a prospective clinical trial should be done.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients

  • Usó, Marta
  • Calabuig-Farinas, Silvia
  • Blasco, Ana
  • Garcia del Olmo, Eva
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Tumors develop mechanisms to recruit tolerogenic immune cells and to induce the expression of molecules that act as immune checkpoints. This regulation of the immune microenvironment favors immune tolerance to the neoplastic cells. In this study, we have investigated the prognostic role of immune-checkpoint expression markers in a cohort of resectable non-small cell lung cancer (NSCLC) patients. RNA was isolated from fresh-frozen lung specimens (tumor and normal lung) (n = 178). RTqPCR was performed to analyze the relative expression of 20 immune-related genes that were normalized by the use of endogenous genes selected by GeNorm algorithm. Patients with higher expression levels of IL23A and LGALS2 presented better outcomes. In the clustering expression patterns, we observed that patients with higher expression of immunoregulatory genes had better survival rates. Additionally, these data were used to develop a gene expression score. Since CTLA4 and PD1 were associated with prognosis based on Cox regression analysis (Z-score > 1.5), a multivariate model including these two genes was created. Absolute regression coefficients from this analysis were used in order to calculate the immunecheckpoint score: (PD1 x 0.116) + (CTLA4 x 0.059) for each case. Kaplan-Meier survival analysis showed that patients with high immune-checkpoint score have longer overall survival (OS) [NR vs. 40.4 mo, p = 0.008] and longer relapse-free survival (RFS) [82.6 vs. 23 mo, p = 0.009]. Multivariate analysis in the entire cohort indicated that the immune-checkpoint score was an independent biomarker of prognosis for OS [HR: 0.308; 95% CI, 0.156-0.609; p = 0.001] and RFS [HR: 0.527; 95% CI, 0.298-0.933; p = 0.028] in early-stage NSCLC patients. In conclusion, this score provides relevant prognostic information for a better characterization of early stage NSCLS patients with strikingly different outcomes and who may be candidates for immune-based therapies., This work was supported by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025) and the Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Validation of DM-Scan, a computer-assisted tool to assess mammographic density in full-field digital mammograms

  • Pollán, Marina
  • Miranda García, Josefa
  • Antón Guirao, Joaquín
  • Casals el Busto, María
  • Martinez Gomez, Inmaculada
  • Palop Jonquères, Carmen
  • Ruiz Perales, Francisco
  • Sanchez Contador, Carmen
  • Vidal, Carmen
  • Perez Gómez, Beatriz
  • Salas Trejo, Dolores
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
We developed a semi-automated tool to assess mammographic density (MD), a phenotype risk marker for breast cancer (BC), in full-field digital images and evaluated its performance testing its reproducibility, comparing our MD estimates with those obtained by visual inspection and using Cumulus, verifying their association with factors that influence MD, and studying the association between MD measures and subsequent BC risk. Three radiologists assessed MD using DM-Scan, the new tool, on 655 processed images (craniocaudal view) obtained in two screening centers. Reproducibility was explored computing pair-wise concordance correlation coefficients (CCC). The agreement between DM-Scan estimates and visual assessment (semi- uantitative scale, 6 categories) was quantified computing weighted kappa statistics (quadratic weights). DM-Scan and Cumulus readings were compared using CCC. Variation of DM-Scan measures by age, body mass index (BMI) and other MD modifiers was tested in regression mixed models with mammographic device as a random-effect term. The association between DM-Scan measures and subsequent BC was estimated in a case control study. All BC cases in screening attendants (2007 2010) at a center with full-field digital mammography were matched by age and screening year with healthy controls (127 pairs). DM-Scan was used to blindly assess MD in available mammograms (112 cases/119 controls). Unconditional logistic models were fitted, including age, menopausal status and BMI as confounders. DM-Scan estimates were very reliable (pairwise CCC: 0.921, 0.928 and 0.916). They showed a reasonable agreement with visual MD assessment (weighted kappa ranging 0.79-0.81). DM-Scan and Cumulus measures were highly concordant (CCC ranging 0.80-0.84), but ours tended to be higher (4%-5% on average). As expected, DM-Scan estimates varied with age, BMI, parity and family history of BC. Finally, DM-Scan measures were significantly associated with BC (p-trend=0.005). Taking MD<7% as reference, OR per categories of MD were: OR7%-17%=1.32 (95% CI=0.59-2.99), OR17%-28%=2.28 (95% CI=1.03-5.04) and OR>=29%=3.10 (95% CI=1.35-7.14). Our results confirm that DM-Scan is a reliable tool to assess MD in full-field digital mammograms., This work was supported by research grants from Spain's Health Research Fund (Fondo de INvestigacion Santiaria) (PI060386 & PI09/1230); Gent per Gent Fund (EDEMAC Project) and the Spanish Federation of Breast Cancer Patients (Federacion Espanola de Cancer de Mama) (FECMA 485 EPY 1170-10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Wonen&apos, s features and inter/intra rater agreement on mammographic density assesment in full-field digital mammograms

  • Perez-Gomez, Beatriz
  • Ruiz, Franciso
  • Martinez, Inmaculada
  • Casals, Maria
  • Miranda, Josefa
  • Sanchez-Contador, Carmen
  • Vidal, Carmen
  • Pollan, Marina
  • Salas, Dolores
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
Measurement of mammographic density (MD), one of the leading risk factors for breast cancer, still relies on subjective assessment. However, the consistency of MD measurement in full-digital mammograms has yet to be evaluated. We studied inter- and intra-rater agreement with respect to estimation of breast density in full-digital mammograms, and tested whether any of the women’s characteristics might have some influence on them. After an initial training period, three experienced radiologists estimated MD using Boyd scale in a left breast craniocaudal mammogram of 1,431 women, recruited at three Spanish screening centres. A subgroup of 50 randomly selected images was read twice to estimate short-term intra-rater agreement. In addition, a reading of 1,428 of the images, performed 2 years before by one rater, was used to estimate long-term intra-rater agreement. Pair-wise weighted kappas with 95% bootstrap confidence intervals were calculated. Dichotomous variables were defined to identify mammograms in which any rater disagreed with other raters or with his/her own assessment, respectively. The association between disagreement and women’s characteristics was tested using multivariate mixed logistic models, including centre as a random-effects term, and taking into account repeated measures when required. All quadratic-weighted kappa values for inter- and intra-rater agreement were excellent (higher than 0.80). None of the studied women’s features, i.e. body mass index, brassiere size, menopause, nulliparity, lactation or current hormonal therapy, was associated with higher risk of inter- or intrarater disagreement. However, raters differed significantly more in images that were classified in the higher-density MD categories, and disagreement in intra-rater assessment was also lower in low-density mammograms. The reliability of MD assessment in full-field digital mammograms is comparable to that for original or digitised images. The reassuring lack of association between subjects’ MD-related characteristics and agreement suggests that bias from this source is unlikely., This study was supported by research grants from Fundacion Gent per Gent (EDEMAC Project); grants FIS PI09/1230 & PI060386 from Spain's Health Research Fund (Fondo de Investigacion Sanitaria); the EPY 1306/06 Collaboration Agreement between Astra-Zeneca and the Carlos III Institute of Health (Instituto de Salud Carlos III); and a grant from the Spanish Federation of Breast Cancer Patients (FECMA). We thank the participants of the study DDM-Spain for their contribution to breast cancer research. We wish also to acknowledge the collaboration from other DDM-Spain members: Pilar Moreo, Pilar Moreno and Soledad Abad (Aragon); Francisca Collado and Magdalena Moya (Baleares); Isabel Gonzalez, Carmen Pedraz and Francisco Casanova (Castilla-Leon); Merce Peris (Cataluna); Carmen Santamarina, Jose Antonio Vazquez Carrete, Montserrat Corujo and Ana Belen Fernandez (Galicia); Nieves Ascunce, Maria Ederra, Milagros Garcia and Ana Barcos (Navarra); Manuela Alcaraz, Jesus Vioque (C. Valenciana); Virginia Lope, Nuria Aragones, Anna Cabanes (Madrid).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers

  • Usó-Marco, Marta
  • Bremnes, Roy M.
  • Calabuig-Fariñas, Silvia
  • Blasco-Cordellat, Ana
  • Pastor, Enrique
  • Borreda, Irene
  • Molina-Pinelo, Sonia
  • Paz-Ares, Luis
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Forteza, Jerónimo
  • Camps-Herrero, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] The prognosis of non-small cell lung cancer (NSCLC) remains poor and heterogeneous and new biomarkers are needed. As the immune system plays a pivotal role in cancer, the study of immune-related markers may provide valuable prognostic information of NSCLC. In 122 formalin-fixed, paraffin-embedded tumor tissue samples from early-stage NSCLC, tumor and tumor-near stromal areas were microdissected and gene expression levels of conventional and regulatory T cell markers were assessed by quantitative polymerase chain reaction. Also, the presence of infiltrating CD4+, CD8+, and FOXP3+ cells in tumor samples was assessed by immunohistochemistry. The relative proportion of conventional and regulatory T cells present in the tumor environment was assessed and found to be key to understand the importance that the immune system analysis has in the prognostics of NSCLC patients. The presence of CD8+ cells in the tumor compartment was associated with better outcome, whereas the presence of FOXP3+ cells was associated with worse overall survival. The negative prognostic value of combined biomarkers, indicating high levels of FOXP3 in the stroma and low levels of CD4 or CD8 in tumors, was observed at mRNA level and was validated by immunohistochemistry. In conclusion, the proportion of T helper and cytotoxic cells vs. regulatory T cells in different locations of the tumor microenvironment have opposite prognostic impacts in resected NSCLC., This work was supported by the Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0025) and the Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838).
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Severity of Bovine Tuberculosis Is Associated with Co-Infection with Common Pathogens in Wild Boar

  • Risco, David
  • Serrano, Emmanuel
  • Fernández-Llario, Pedro
  • Cuesta, Jesús M.
  • Gonçalves, Pilar
  • García-Jiménez, Waldo L.
  • Martínez, Remigio
  • Cerrato, Rosario
  • Velarde, Roser
  • Gómez, Luis
  • Segalés, Joaquim
  • Hermoso de Mendoza, Javier
Co-infections with parasites or viruses drive tuberculosis dynamics in humans, but little is known about their effects in other non-human hosts. This work aims to investigate the relationship between Mycobacterium bovis infection and other pathogens in wild boar (Sus scrofa), a recognized reservoir of bovine tuberculosis (bTB) in Mediterranean ecosystems. For this purpose, it has been assessed whether contacts with common concomitant pathogens are associated with the development of severe bTB lesions in 165 wild boar from mid-western Spain. The presence of bTB lesions affecting only one anatomic location (cervical lymph nodes), or more severe patterns affecting more than one location (mainly cervical lymph nodes and lungs), was assessed in infected animals. In addition, the existence of contacts with other pathogens such as porcine circovirus type 2 (PCV2), Aujeszky’s disease virus (ADV), swine influenza virus, porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Haemophilus parasuis and Metastrongylus spp, was evaluated by means of serological, microbiological and parasitological techniques. The existence of contacts with a structured community of pathogens in wild boar infected by M. bovis was statistically investigated by null models. Association between this community of pathogens and bTB severity was examined using a Partial Least Squares regression approach. Results showed that adult wild boar infected by M. bovis had contacted with some specific, non-random pathogen combinations. Contact with PCV2, ADV and infection by Metastrongylus spp, was positively correlated to tuberculosis severity. Therefore, measures against these concomitant pathogens such as vaccination or deworming, might be useful in tuberculosis control programmes in the wild boar. However, given the unexpected consequences of altering any community of organisms, further research should evaluate the impact of such measures under controlled conditions. Furthermore, more research including other important pathogens, such as gastro-intestinal nematodes, will be necessary to complete this picture., info:eu-repo/semantics/publishedVersion
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Reliability and validity of the reduced Spanish version of the Prenatal Breastfeeding Self-Efficacy Scale: A longitudinal instrumental study

  • Silva-Tubio, José R.
  • Oliver-Roig, Antonio
  • Perpiñá-Galvañ, Juana
  • Richart-Martínez, Miguel
  • Oliver-Roig, Antonio|||/items/32f85786-4909-4294-89dd-278bc92294e9
  • Perpiñá-Galvañ, Juana|||/items/ac9198ab-2c8c-4d97-90ae-458ac226f6f6
  • Richart-Martínez, Miguel|||/items/9e930f71-f758-4e11-a265-86159a9b0bf7
Breastfeeding self-efficacy is a relevant predictor of exclusive breastfeeding during the first six months of life. The Prenatal Breastfeeding Self-Efficacy Scale (PBSES) is a 20-item tool developed to determine breastfeeding self-efficacy during pregnancy. Our study aimed to assess the structural validity and psychometric characteristics of the PBSES and to explore item reduction according to the statistical criteria for parsimony and incremental validity. In this study, conducted in six hospitals in eastern Spain, we recruited 1183 women with healthy, full-term, single-birth newborns. Data on sociodemographic, breastfeeding-related variables, and the PBSES, were obtained from self-administered questionnaires during the third trimester of pregnancy, at postpartum discharge, and 5 months postpartum, and from a phone survey 12 months postpartum. Item reduction was conducted after revising the PBSES item floor and ceiling effects, interitem correlations, and item–score relationships with breastfeeding-status variables during follow-up. The factorial structure of the short form of the PBSES (PBSES-SF) was tested using both exploratory and confirmatory approaches. After item reduction, the confirmatory factor analysis of the 12 remaining items of the PBSES-SF revealed adequate fit statistics for a three-factor structure and a second-order factor. Internal consistency was measured using the Cronbach's α coefficient of the PBSES-SF (0.86). We provided evidence on the discriminant validity of the PBSES-SF by comparing its scores between known groups, convergent validity by examining its correlations with other variables, and predictive validity by assessing the association of PBSES-SF scores with breastfeeding behavior at critical points in time during the first postpartum year.
Arias Montano. Repositorio Institucional de la Universidad de Huelva
Publicación Artículo científico (JournalArticle)

Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study

  • Huerta, José M.
  • Ramos Lora, Manuel
  • Aragonés, Nuria
Background Evidence for a protective role of physical activity against development of stomach cancer is yet inconclusive. We studied the association of domain-specific physical activity and the risk of gastric adenocarcinoma (GAC), by site and histology, in the MCC-Spain case-control study. Methods 428 histologically confirmed GAC cases (67% men) including the gastro-esophageal region and 3225 controls were included. Cases were recruited in hospitals from 10 different Spanish regions, whereas population controls were randomly selected within the respective hospitals' catchment areas. A physical activity (PA) questionnaire was used to gather information on household and recreational activities, allowing estimation of PA volume (in metabolic equivalents (MET)-min/week). Participants also reported the intensity of working PA and daily sitting time. Questionnaire data on diet, lifestyles and clinical variables including Helicobacter pylori serology were available. Adjusted odds ratios (OR) of GAC were estimated for domains of physical activity, stratifying by sex, site (cardia vs. non-cardia), and Lauren classification (intestinal vs. diffuse). Results Household physical activity (HPA) showed a strong inverse association with GAC, observed for both cardia and non-cardia tumours. Risk of overall gastric cancer was 50% lower risk among participants in the highest HPA category (OR = 0.50, 95`)Cl: 0.38, 0.66). Recreational physical activity (RPA) was also associated with lower overall GAC risk (OR = 0.68, 95% CI: 0.52, 0.88), particularly at moderate levels of intensity such as walking (OR = 0.61, 95% CI: 0.46, 0.79). The protective effect of RPA was strongest for non-cardia tumours. Sedentary time was not related to GAC risk (p-trend = 0.392), but the potential protective effect of RPA was restricted to non -sedentary participants. Conclusions Both household and recreational physical activities were independently related to lower GAC risk in the MCC-Spain study.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in meniere's disease

  • Cabrera, S.
  • Sanchez, E.
  • Requena, T.
  • Martinez-Bueno, M.
  • Benitez, J.
  • Perez, N.
  • Trinidad, G.
  • Soto-Varela, A.
  • Santos-Perez, S.
  • Martin-Sanz, E.
  • Fraile, J.
  • Perez, P.
  • Alarcon-Riquelme, M.
  • Batuecas, A.
  • Espinosa-Sanchez, J.
  • Aran, I.
  • Lopez-Escamez, J.
Meniere's disease is an episodic vestibular syndrome associated with sensorineural hearing loss (SNHL) and tinnitus. Patients with MD have an elevated prevalence of several autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and psoriasis), which suggests a shared autoimmune background. Functional variants of several genes involved in the NF-¿B pathway, such as REL, TNFAIP3, NFKB1 and TNIP1, have been associated with two or more immune-mediated diseases and allelic variations in the TLR10 gene may influence bilateral affectation and clinical course in MD. We have genotyped 716 cases of MD and 1628 controls by using the ImmunoChip, a high-density genotyping array containing 186 autoimmune loci, to explore the association of immune system related-loci with sporadic MD. Although no single nucleotide polymorphism (SNP) reached a genome-wide significant association (p<10-8), we selected allelic variants in the NF-kB pathway for further analyses to evaluate the impact of these SNPs in the clinical outcome of MD in our cohort. None of the selected SNPs increased susceptibility for MD in patients with uni or bilateral SNHL. However, two potential regulatory variants in the NFKB1 gene (rs3774937 and rs4648011) were associated with a faster hearing loss progression in patients with unilateral SNHL. So, individuals with unilateral MD carrying the C allele in rs3774937 or G allele in rs4648011 had a shorter mean time to reach hearing stage 3 (>40 dB HL) (log-rank test, corrected p values were p¿=¿0.009 for rs3774937 and p¿=¿0.003 for rs4648011, respectively). No variants influenced hearing in bilateral MD. Our data support that the allelic variants rs3774937 and rs4648011 can modify hearing outcome in patients with MD and unilateral SNHL.
Repositorio Digital UPCT
Publicación Artículo científico (JournalArticle)

Control and synchronization algorithms for a grid-connected photovoltaic system under harmonic distortions, frequency variations and unbalances

  • Guerrero Rodríguez, Nestór Francisco
  • Rey Boué, Alexis Bonifacio
  • Herrero-de Lucas, Luis C.
  • Martinez Rodrigo, Fernando
In this paper, an implementation of the control and the synchronization algorithms for a Voltage Source Inverter used as the power conditioner for Photovoltaic renewable energy in a grid-connected structure is carried out. Its main purpose is to show, in a simple manner, the design and combined operation of the control and synchronization algorithms for attaining the proper behaviour of the Grid Inverter when the 3-phase utility grid is disturbed by voltage unbalances, frequency variations and harmonic distortions, according to power quality standards. In order to obtain a high efficiency of the system during perturbations, a Proportional Resonant controller with a Harmonic Compensator structure is designed for the control algorithm, whereas a Dual Second Order Generalized Integrator Frequency-Locked Loop (DSOGI-FLL) is used as the synchronization algorithm. In order to validate both the control and the synchronization algorithms, some simulations using MATLAB/SIMULINK from The MathWorks, Inc. are shown firstly, and secondly, some real-time digital simulations are carried out., This work has been supported by a grant from La Fundación Séneca, Agencia de Ciencia y Tecnología de la Región de Murcia, Spain, as a part of the Project Ref.11948/PI/09, entitled “Design and construction of a hardware/software prototype for the synchronization and monitoring of renewable agents in a Distributed Generation System” (Alexis. B. Rey-Boué), and a scholarship towards the PhD degree from the Universidad Politécnica de Cartagena, Spain, with the Santander Bank support (N. F. Guerrero-Rodríguez).
Repositorio Digital UPCT
Publicación Artículo científico (JournalArticle)

Overview and comparative study of two control strategies used in 3-phase grid-connected inverters for renewable systems

  • Guerrero Rodríguez, Nestór Francisco
  • Rey Boué, Alexis Bonifacio
  • Reyes Archundia, Enrique
In this paper, an overview of grid-connected renewable systems is presented, then twocurrent-control strategies for 3-phase grid-connected inverters are analyzed: firstly, the well-known d-q control in the rotating synchronous reference frame (d-q axes) using Proportional Integral regulators is described, and secondly, the Proportional Resonant controller in the stationary reference frame (αβ axes). In order to obtain a high efficiency of the system when the 3-phase utility grid voltages are affected by harmonic pollution, a Harmonic Compensator (HC) structure is used with the Proportional Resonant controller, this due to the ease way to compensate harmonics when a Proportional Resonant control is utilized instead of a d-q control. Then both control strategies (d-qcontrol and PR+HC) are analyzed under harmonic pollution condition. For both strategies, a Positive Sequence Detector plus a Synchronous Reference Frame PhaseLook Loop (PSD+dqPLL) is used as the synchronization algorithm. After the study, it was observed that the PR controller provides a greater facility for carrying out the harmonic compensation process helping to fulfil with the international standards. A model of a grid-connected photovoltaic system with a nominal power of 10kW is used to evaluate and compare the performance of the current-control strategies. For this, a Real-Time Digital Simulator (RTDS) platform is used., This work has been supported by a grant from La Fundación Séneca, Agencia de Ciencia y Tecnología de la Región de Murcia, Spain, as a part of the Project Ref.11948/PI/09, entitled ‘‘Design and construction of a hardware/software prototype for the synchronization and monitoring of renewable agents in a Distributed Generation System’’.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM

  • Llauradó Cabot, Gemma
  • Cano, Albert
  • Albert, Lara
  • Ballesta, Silvia
  • Mazarico, Isabel
  • Luchtenberg, María F.
  • Simó Canonge, Rafael
Steno Type 1 Risk Engine (ST1RE); Arterial stiffness; Type 1 diabetes (T1DM), Motor de Risc Steno Tipus 1; Rigidesa arterial; Diabetis mellitus tipus 1 (DM1), Motor de Riesgo Steno Tipo 1; Rigidez arterial; Diabetes mellitus tipo 1 (DM1), OBJECTIVES: Currently used risk scores for type 2 diabetes mellitus (T2DM) clearly underestimate cardiovascular risk in type 1 diabetes (T1DM). Hence, there is a need to develop novel and specific risk-estimation tools for this population. We aimed to assess the relationship between the Steno Type 1 Risk Engine (ST1RE) and arterial stiffness (AS), and to identify potential cut-off points of interest in clinical practice. DESIGN AND METHODS: A total of 179 patients with T1DM (50.8% men, mean age 41.2±13.1 years), without established cardiovascular disease, were evaluated for clinical and anthropometric data (including classical cardiovascular risk factors), and AS measured by aortic pulse-wave velocity (aPWV). The ST1RE was used to estimate 10-year cardiovascular risk and patients were classified into 3 groups: low- (<10%; n = 105), moderate- (10-20%; n = 53) and high-risk (≥20%; n = 21). RESULTS: When compared with the low- and moderate-risk groups, patients in the high-risk group were older, had higher prevalence of hypertension, dyslipidemia and insulin-resistance, and had higher body-mass index and HbA1c. aPWV increased in parallel with estimated cardiovascular risk (6.4±1.0, 8.4±1.3 and 10.3±2.6m/s; p<0.001). As an evaluation of model performance, the C-statistic of aPWV was 0.914 (95% confidence interval [CI]:0.873-0.950) for predicting moderate/high-risk and 0.879 (95%CI:0.809-0.948) for high-risk, according to the ST1RE. The best cut-off points of aPWV were 7.3m/s (sensitivity:86%, specificity:83%) and 8.7m/s (sensitivity:76%, specificity:86%) for moderate/high- and high-risk, respectively. CONCLUSIONS: AS is highly correlated with the scores obtained from the ST1RE. We have identified two cut-off points of AS that can clearly discriminate moderate/high- and high-risk T1DM patients, which could be of great value in clinical practice., Financial support was provided through the Fondo de Investigacion Sanitaria (FIS) PI09/01360 (PI: JMCG), PI12/00954 (PI: JMCG) and PI15/00567 (PI: JMCG) as part of the National R+D+I (2008-2011) and was co-financed by the Instituto de Salud Carlos III - General Evaluation Branch (Spanish Ministry of Economy and Competitiveness) and the European Regional Development Fund (ERDF). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Severity of Bovine Tuberculosis Is Associated with Co-Infection with Common Pathogens in Wild Boar

  • Risco, David
  • Serrano, Emmanuel
  • Fernández-Llario, Pedro
  • Cuesta, Jesús M.
  • Gonçalves, Pilar
  • García-Jiménez, Waldo L.
  • Martínez, Remigio
  • Cerrato, Rosario
  • Velarde, Roser
  • Gómez, Luis
  • Segalés, Joaquim
  • Hermoso de Mendoza, Javier
Co-infections with parasites or viruses drive tuberculosis dynamics in humans, but little is known about their effects in other non-human hosts. This work aims to investigate the relationship between Mycobacterium bovis infection and other pathogens in wild boar (Sus scrofa), a recognized reservoir of bovine tuberculosis (bTB) in Mediterranean ecosystems. For this purpose, it has been assessed whether contacts with common concomitant pathogens are associated with the development of severe bTB lesions in 165 wild boar from mid-western Spain. The presence of bTB lesions affecting only one anatomic location (cervical lymph nodes), or more severe patterns affecting more than one location (mainly cervical lymph nodes and lungs), was assessed in infected animals. In addition, the existence of contacts with other pathogens such as porcine circovirus type 2 (PCV2), Aujeszky’s disease virus (ADV), swine influenza virus, porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Haemophilus parasuis and Metastrongylus spp, was evaluated by means of serological, microbiological and parasitological techniques. The existence of contacts with a structured community of pathogens in wild boar infected by M. bovis was statistically investigated by null models. Association between this community of pathogens and bTB severity was examined using a Partial Least Squares regression approach. Results showed that adult wild boar infected by M. bovis had contacted with some specific, non-random pathogen combinations. Contact with PCV2, ADV and infection by Metastrongylus spp, was positively correlated to tuberculosis severity. Therefore, measures against these concomitant pathogens such as vaccination or deworming, might be useful in tuberculosis control programmes in the wild boar. However, given the unexpected consequences of altering any community of organisms, further research should evaluate the impact of such measures under controlled conditions. Furthermore, more research including other important pathogens, such as gastro-intestinal nematodes, will be necessary to complete this picture., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

  • Ruiz de Porras, Vicenç
  • Bystrup, Sara
  • Cabrero-de Las Heras, Sara
  • Musulén, Eva
  • Palomero, Luis
  • Henar Alonso, Maria
  • Arango Corro, Diego
  • Nieto Raya, Rocio
Colorectal cancer; Cyclin-dependent kinase 5 (Cdk5); Prognostic and predictive biomarker, Cáncer colorrectal; Quinasa dependiente de ciclina 5 (Cdk5); Biomarcador pronóstico y predictivo, Càncer colorectal; Quinasa dependent de ciclina 5 (CDK5); Biomarcador pronòstic i predictiu, In recent years, an increasing number of studies have shown that elevated expression of cyclin dependent kinase (Cdk5) contributes to the oncogenic initiation and progression of many types of cancers. In this study, we investigated the expression pattern of Cdk5 in colorectal cancer (CRC) cell lines and in a large number of tumor samples in order to evaluate its relevance in this pathogenesis and possible use as a prognostic marker. We found that Cdk5 is highly expressed and activated in CRC cell lines and that silencing of the kinase decreases their migration ability. In tumor tissues, Cdk5 is overexpressed compared to normal tissues due to a copy number gain. In patients with localized disease, we found that high Cdk5 levels correlate with poor prognosis, while in the metastatic setting, this was only the case for patients receiving an oxaliplatin-based treatment. When exploring the Cdk5 levels in the consensus molecular subtypes (CMS), we found the lowest levels in subtype 1, where high Cdk5 again was associated with a poorer prognosis. In conclusion, we confirm that Cdk5 is involved in CRC and disease progression and that it could serve as a prognostic and predictive biomarker in this disease., This work has been funded by the ISCIII grants from the Spanish Government, project numbers PI09/01334 and PI12/02228, and the Departament d’Innovació, Universitats i Empresa, Generalitat de Catalunya, project numbers 2014-SGR-1494, 2017-SGR-1705 and 2017-SGR-723. The group from Eva Martinez Balibrea is furthermore funded by the PIE16/00011 and the group from Diego Arango by the PI16/00540 and AC15/00066 grants.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome

  • García Castaño, Alejandro
  • Pérez de Nanclares, Gustavo
  • Madariaga, Leire
  • Aguirre, Mireia
  • Madrid Aris, Alvaro Domingo
  • Chocron de Benzaquen, Sara
  • Ariceta Iraola, Gema
Excreció; Genètica humana; Mutació, Excreción; Genética humana; Mutación, Excretion; Human genetics; Mutation, Introduction Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p.Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS. Methods Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses. Results Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype. Conclusion A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort, This study was supported by two grants (PI09/90888 and PI11/01412) from the FIS of the Instituto de Salud Carlos III, Madrid, Spain, the Department of Health of the Basque Government (2014111064), and the Department of Education of the Basque Government (IT795-13).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prediction of absolute risk of fragility fracture at 10 years in a Spanish population, validation of the WHO FRAX ™ tool in Spain

  • Azagra Ledesma, Rafael|||0000-0003-0093-333X
  • Roca Figueras, Genís
  • Encabo, Gloria|||0000-0002-1575-1005
  • Prieto-Alhambra, Daniel|||0000-0002-3950-6346
  • Aguyé Batista, Amada|||0000-0002-2674-3633
  • Zwart, Marta|||0000-0003-4888-0927
  • Güell Parnau, Sílvia|||0000-0002-4390-5155
  • Puchol, Núria
  • Gené Tous, Emilio|||0000-0001-8916-2919
  • Casado, Enrique|||0000-0001-8839-6430
  • Sancho, Pilar
  • Solà, Sílvia
  • Torán, Pere
  • Iglesias, Milagros
  • Sabaté, Victòria
  • López-Expósito, Francesc
  • Ortiz, Sergio
  • Fernandez-Hermida, Yolanda
  • Díez Pérez, Adolfo|||0000-0001-8162-0209
Age-related bone loss is asymptomatic, and the morbidity of osteoporosis is secondary to the fractures that occur. Common sites of fracture include the spine, hip, forearm and proximal humerus. Fractures at the hip incur the greatest morbidity and mortality and give rise to the highest direct costs for health services. Their incidence increases exponentially with age. Independently changes in population demography, the age - and sex- specific incidence of osteoporotic fractures appears to be increasing in developing and developed countries. This could mean more than double the expected burden of osteoporotic fractures in the next 50 years. To assess the predictive power of the WHO FRAX™ tool to identify the subjects with the highest absolute risk of fragility fracture at 10 years in a Spanish population, a predictive validation study of the tool will be carried out. For this purpose, the participants recruited by 1999 will be assessed. These were referred to scan-DXA Department from primary healthcare centres, non hospital and hospital consultations. Study population: Patients attended in the national health services integrated into a FRIDEX cohort with at least one Dual-energy X-ray absorptiometry (DXA) measurement and one extensive questionnaire related to fracture risk factors. Measurements: At baseline bone mineral density measurement using DXA, clinical fracture risk factors questionnaire, dietary calcium intake assessment, history of previous fractures, and related drugs. Follow up by telephone interview to know fragility fractures in the 10 years with verification in electronic medical records and also to know the number of falls in the last year. The absolute risk of fracture will be estimated using the FRAX™ tool from the official web site. Since more than 10 years ago numerous publications have recognised the importance of other risk factors for new osteoporotic fractures in addition to low BMD. The extension of a method for calculating the risk (probability) of fractures using the FRAX™ tool is foreseeable in Spain and this would justify a study such as this to allow the necessary adjustments in calibration of the parameters included in the logarithmic formula constituted by FRAX™.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

FRAX® tool, the WHO algorithm to predict osteoporotic fractures, the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort

  • Azagra Ledesma, Rafael|||0000-0003-0093-333X
  • Roca, Genís
  • Encabo, Gloria|||0000-0002-1575-1005
  • Aguyé Batista, Amada|||0000-0002-2674-3633
  • Zwart, Marta|||0000-0003-4888-0927
  • Güell Parnau, Sílvia|||0000-0002-4390-5155
  • Puchol, Núria
  • Gené Tous, Emilio|||0000-0001-8916-2919
  • Casado, Enrique|||0000-0001-8839-6430
  • Sancho, Pilar
  • Solà, Silvia
  • Torán, Pere
  • Iglesias, Milagros
  • Gisbert, Maria Carmen
  • López-Expósito, Francesc
  • Pujol Salud, Jesús|||0000-0001-6062-2627
  • Fernandez-Hermida, Yolanda
  • Puente, Ana
  • Rosàs, Mireia
  • Bou, Vicente
  • Antón, Juan José
  • Lansdberg, Gustavo
  • Martín Sánchez, Juan Carlos
  • Díez Pérez, Adolfo|||0000-0001-8162-0209
  • Prieto-Alhambra, Daniel|||0000-0002-3950-6346
The WHO has recently published the FRAX® tool to determine the absolute risk of osteoporotic fracture at 10 years. This tool has not yet been validated in Spain. A prospective observational study was undertaken in women in the FRIDEX cohort (Barcelona) not receiving bone active drugs at baseline. Baseline measurements: known risk factors including those of FRAX® and a DXA. Follow up data on self-reported incident major fractures (hip, spine, humerus and wrist) and verified against patient records. The calculation of absolute risk of major fracture and hip fracture was by FRAX® website. This work follows the guidelines of the STROBE initiative for cohort studies. The discriminative capacity of FRAX® was analyzed by the Area Under Curve (AUC), Receiver Operating Characteristics (ROC) and the Hosmer-Lemeshow goodness-of-fit test. The predictive capacity was determined using the ratio of observed fractures/expected fractures by FRAX® (ObsFx/ExpFx). The study subjects were 770 women from 40 to 90 years of age in the FRIDEX cohort. The mean age was 56.8 ± 8 years. The fractures were determined by structured telephone questionnaire and subsequent testing in medical records at 10 years. Sixty-five (8.4%) women presented major fractures (17 hip fractures). Women with fractures were older, had more previous fractures, more cases of rheumatoid arthritis and also more osteoporosis on the baseline DXA. The AUC ROC of FRAX® for major fracture without bone mineral density (BMD) was 0.693 (CI 95%; 0.622-0.763), with T-score of femoral neck (FN) 0.716 (CI 95%; 0.646-0.786), being 0.888 (CI 95%; 0.824-0.952) and 0.849 (CI 95%; 0.737-0.962), respectively for hip fracture. In the model with BMD alone was 0.661 (CI 95%; 0.583-0.739) and 0.779 (CI 95%; 0.631-0.929). In the model with age alone was 0.668 (CI 95%; 0.603-0.733) and 0.882 (CI 95%; 0.832-0.936). In both cases there are not significant differences against FRAX® model. The overall predictive value for major fracture by ObsFx/ExpFx ratio was 2.4 and 2.8 for hip fracture without BMD. With BMD was 2.2 and 2.3 respectively. Sensitivity of the four was always less than 50%. The Hosmer-Lemeshow test showed a good correlation only after calibration with ObsFx/ExpFx ratio. The current version of FRAX® for Spanish women without BMD analzsed by the AUC ROC demonstrate a poor discriminative capacity to predict major fractures but a good discriminative capacity for hip fractures. Its predictive capacity does not adjust well because leading to underdiagnosis for both predictions major and hip fractures. Simple models based only on age or BMD alone similarly predicted that more complex FRAX® models.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder

  • Amann, Benedikt L.|||0000-0002-4407-1519
  • Canales-Rodriguez, Erick Jorge|||0000-0001-6421-2633
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Radua, Joaquim|||0000-0003-1240-5438
  • Monte, G.
  • Alonso-Lana, Silvia|||0000-0002-3063-6929
  • Landin-Romero, Ramon|||0000-0003-0485-8090
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ortiz-Gil, Jordi|||0000-0001-7910-8062
  • Gomar, J. J.
  • Moro, N.
  • Fernandez-Corcuera, P.
  • Goikolea Alberdi, Jose Manuel|||0000-0003-0676-0791
  • Blanch, J.
  • Salvador, R.
  • Vieta, Eduard|||0000-0002-0548-0053
  • McKenna, P. J.
  • Pomarol-Clotet, E.
Brain structural changes in schizoaffective disorder, and how far they resemble those seen in schizophrenia and bipolar disorder, have only been studied to a limited extent. Forty-five patients meeting - and criteria for schizoaffective disorder, groups of patients with 45 matched schizophrenia and bipolar disorder, and 45 matched healthy controls were examined using voxel-based morphometry (). Analyses comparing each patient group with the healthy control subjects found that the patients with schizoaffective disorder and the patients with schizophrenia showed widespread and overlapping areas of significant volume reduction, but the patients with bipolar disorder did not. A subsequent analysis compared the combined group of patients with the controls followed by extraction of clusters. In regions where the patients differed significantly from the controls, no significant differences in mean volume between patients with schizoaffective disorder and patients with schizophrenia in any of five regions of volume reduction were found, but mean volumes in the patients with bipolar disorder were significantly smaller in three of five. The findings provide evidence that, in terms of structural gray matter brain abnormality, schizoaffective disorder resembles schizophrenia more than bipolar disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validity of the CR-POSSUM model in surgery for colorectal cancer in Spain (CCR-CARESS Study) and comparison with other models to predict operative mortality

  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Alcántara Moral, Manuel Jesús
  • Gil, Maria José
  • Collera-Ormazabal, Pablo|||0000-0002-0517-5382
  • Pont, Marina
  • Escobar, Antonio
  • Sarasqueta, Cristina
  • Redondo, Maximino
  • Briones, Eduardo
  • Dujovne, Paula
  • Quintana López, José María|||0000-0003-2170-7876
Background: To validate and recalibrate the CR- POSSUM model and compared its discriminatory capacity with other European models such as POSSUM, P-POSSUM, AFC or IRCS to predict operative mortality in surgery for colorectal cancer. Methods: Prospective multicenter cohort study from 22 hospitals in Spain. We included patients undergoing planned or urgent surgery for primary invasive colorectal cancers between June 2010 and December 2012 (N= 2749). Clinical data were gathered through medical chart review. We validated and recalibrated the predictive models using logistic regression techniques. To calculate the discriminatory power of each model, we estimated the areas under the curve - AUC (95% CI). We also assessed the calibration of the models by applying the Hosmer-Lemeshow test. Results: In-hospital mortality was 1.5% and 30-day mortality, 1.7%. In the validation process, the discriminatory power of the CR-POSSUM for predicting in-hospital mortality was 73.6%. However, in the recalibration process, the AUCs improved slightly: the CR-POSSUM reached 75.5% (95% CI: 67.3-83.7). The discriminatory power of the CR-POSSUM for predicting 30-day mortality was 74.2% (95% CI: 67.1-81.2) after recalibration; among the other models the POSSUM had the greatest discriminatory power, with an AUC of 77.0% (95% CI: 68.9-85.2). The Hosmer-Lemeshow test showed good fit for all the recalibrated models. Conclusion: The CR-POSSUM and the other models showed moderate capacity to discriminate the risk of operative mortality in our context, where the actual operative mortality is low. Nevertheless the IRCS might better predict in-hospital mortality, with fewer variables, while the CR-POSSUM could be slightly better for predicting 30-day mortality.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex

  • Guadalupe, Tulio
  • Mathias, Samuel R.
  • vanErp, Theo G. M.
  • Whelan, Christopher D.|||0000-0003-0308-5583
  • Zwiers, Marcel P.|||0000-0001-5483-2935
  • Abe, Yoshinari|||0000-0001-8348-0801
  • Abramovic, Lucija
  • Agartz, Ingrid|||0000-0002-9839-5391
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Aribisala, Benjamin S.
  • Armstrong, Nicola|||0000-0002-4477-293X
  • Arolt, Volker|||0000-0002-2445-9778
  • Artiges, Eric
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
  • Baboyan, Vatche G.
  • Banaschewski, Tobias
  • Barker, Gareth John|||0000-0002-5214-7421
  • Bastin, Mark E.
  • Baune, Bernhard T.|||0000-0001-6548-426X
  • Blangero, John
  • Bokde, Arun L. W.
  • Boedhoe, Premika
  • Bose, Anushree|||0000-0002-3394-1646
  • Brem, Silvia
  • Brodaty, Henry|||0000-0001-9487-6617
  • Bromberg, Uli
  • Brooks, Samantha
  • Büchel, Christian
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Calhoun, Vince
  • Cannon, Dara M.
  • Cattrell, Anna
  • Cheng, Yuqi
  • Conrod, Patricia
  • Conzelmann, Annette
  • Corvin, Aiden
  • Crespo-Facorro, Benedicto|||0000-0003-0033-7132
  • Crivello, Fabrice|||0000-0001-6950-984X
  • Dannlowski, Udo|||0000-0002-0623-3759
  • de Zubicaray, Greig|||0000-0003-4506-0579
  • De Zwarte, Sonja M. C.
  • Deary, Ian J.|||0000-0002-1733-263X
  • Desrivières, Sylvane|||0000-0002-9120-7060
  • Doan, Nhat Trung
  • Donohoe, Gary
  • Dørum, Erlend S.
  • Ehrlich, Stefan|||0000-0003-2132-4445
  • Espeseth, Thomas
  • Fernández, Guillén
  • Flor, Herta|||0000-0003-4809-5398
  • Fouche, Jean-Paul|||0000-0002-0830-2324
  • Frouin, Vincent
  • Fukunaga, Masaki
  • Gallinat, Jürgen
  • Garavan, Hugh P.
  • Gill, Michael
  • Suarez, Andrea Gonzalez
  • Gowland, Penny
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Hagenaars, Saskia
  • Hashimoto, Ryota
  • Hauser, Tobias U.|||0000-0002-7997-8137
  • Heinz, Andreas
  • Hibar, Derrek P.
  • Hoekstra, Pieter J.
  • Hoogman, Martine|||0000-0002-1261-7628
  • Howells, Fleur M.|||0000-0001-9759-2556
  • Hu, Hao
  • Hulshoff Pol, Hilleke E.|||0000-0002-2038-5281
  • Huyser, Chaim|||0000-0001-8757-3124
  • Ittermann, Bernd
  • Jahanshad, Neda|||0000-0003-4401-8950
  • Jönsson, Erik G.|||0000-0001-8368-6332
  • Jurk, Sarah
  • Kahn, Rene S.
  • Kelly, Sinead
  • Kraemer, Bernd
  • Kugel, Harald
  • Kwon, Jun Soo|||0000-0002-1060-1462
  • Lemaitre, Herve
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Lochner, Christine|||0000-0002-4766-3704
  • Luciano, Michelle|||0000-0002-7306-3008
  • Marquand, Andre F.|||0000-0001-5903-203X
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Martinot, Jean-Luc
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Mather, Karen A.|||0000-0003-4143-8941
  • McDonald, Colm|||0000-0003-1661-5192
  • McMahon, Katie L.
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Morris, Derek W.
  • Mothersill, Omar
  • Maniega, Susana Munoz
  • Mwangi, Benson|||0000-0002-1717-4395
  • Nakamae, Takashi|||0000-0003-4265-198X
  • Nakao, Tomohiro
  • Narayanaswaamy, Janardhanan C.
  • Nees, Frauke|||0000-0002-7796-8234
  • Nordvik, Jan E.
  • Onnink, A. Marten H.
  • Opel, Nils
  • Ophoff, Roel
  • Paillère Martinot, Marie-Laure
  • Papadopoulos Orfanos, Dimitri
  • Pauli, Paul
  • Paus, Tomáš
  • Poustka, Luise
  • Reddy, Janardhan YC.
  • Rentería, Miguel E.|||0000-0003-4626-7248
  • Roiz-Santiáñez, Roberto
  • Roos, Annerine
  • Royle, Natalie A.
  • Sachdev, Perminder
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Schmaal, Lianne|||0000-0001-9822-048X
  • Schumann, Gunter
  • Shumskaya, Elena
  • Smolka, Michael N.
  • Soares, Jair C.|||0000-0002-5466-5628
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Stein, Dan J.|||0000-0001-7218-7810
  • Strike, Lachlan|||0000-0003-2885-5898
  • Toro, Roberto
  • Turner, Jessica A.
  • Tzourio-Mazoyer, Nathalie
  • Uhlmann, Anne|||0000-0002-1753-7811
  • Hernández, Maria Valdés
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • van der Meer, Dennis|||0000-0002-0466-386X
  • van Haren, Neeltje E. M.
  • Veltman, Dick J.
  • Venkatasubramanian, Ganesan|||0000-0002-0949-898X
  • Vetter, Nora C.
  • Vuletic, Daniella
  • Walitza, Susanne|||0000-0002-8161-8683
  • Walter, Henrik|||0000-0002-9403-6121
  • Walton, Esther|||0000-0002-0935-2200
  • Wang, Zhen|||0000-0003-4319-5314
  • Wardlaw, Joanna|||0000-0002-9812-6642
  • Wen, Wei|||0000-0003-2753-3870
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Whelan, Robert
  • Wittfeld, Katharina|||0000-0003-4383-5043
  • Wolfers, Thomas
  • Wright, Margaret J.|||0000-0001-7133-4970
  • Xu, Jian
  • Xu, Xiufeng
  • Yun, Je-Yeon|||0000-0002-5531-2410
  • Zhao, Jingjing
  • Franke, Barbara|||0000-0003-4375-6572
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Glahn, David C.|||0000-0002-4749-6977
  • Mazoyer, Bernard|||0000-0003-0970-2837
  • Fisher, Simon E.|||0000-0002-3132-1996
  • Francks, Clyde|||0000-0002-9098-890X
The online version of this article (doi:10.1007/s11682-016-9629-z) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer, a nationwide study in Spain

  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Montón, Concepción
  • Mora, Laura
  • Redondo, Maximino
  • Pont, Marina
  • Escobar, Antonio
  • Sarasqueta, Cristina
  • Fernández de Larrea, Nerea
  • Briones, Eduardo
  • Quintana López, José María|||0000-0003-2170-7876
We hypothesized that patients undergoing surgery for colorectal cancer (CRC) with COPD as a comorbidity would consume more resources and have worse in-hospital outcomes than similar patients without COPD. Therefore, we compared different aspects of the care process and short-term outcomes in patients undergoing surgery for CRC, with and without COPD. This was a prospective study and it included patients from 22 hospitals located in Spain - 472 patients with COPD and 2,276 patients without COPD undergoing surgery for CRC. Clinical variables, postintervention intensive care unit (ICU) admission, use of invasive mechanical ventilation, and postintervention antibiotic treatment or blood transfusion were compared between the two groups. The reintervention rate, presence and type of complications, length of stay, and in-hospital mortality were also estimated. Hazard ratio (HR) for hospital mortality was estimated by Cox regression models. COPD was associated with higher rates of in-hospital complications, ICU admission, antibiotic treatment, reinterventions, and mortality. Moreover, after adjusting for other factors, COPD remained clearly associated with higher and earlier in-hospital mortality. To reduce in-hospital morbidity and mortality in patients undergoing surgery for CRC and with COPD as a comorbidity, several aspects of perioperative management should be optimized and attention should be given to the usual comorbidities in these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome

  • García, Alejandro|||0000-0002-9734-6600
  • Pérez de Nanclares, Gustavo
  • Madariaga, Leire|||0000-0002-4032-9842
  • Aguirre, Mireia
  • Madrid, Alvaro
  • Chocron, Sara
  • Nadal, Inmaculada
  • Navarro, Mercedes
  • Lucas, Elena
  • Fijo, Julia
  • Espino, Mar
  • Espitaletta, Zilac
  • Garcia-Nieto, Víctor Manuel
  • Barajas de Frutos, David
  • Loza, Reyner
  • Pintos-Morell, Guillem|||0000-0002-9347-2386
  • Castaño, Luis|||0000-0003-0437-9401
  • Ariceta Iraola, Gema|||0000-0003-1763-1098
Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p.Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS. Methods. Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses. Results. Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype. Conclusion. A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Emerging roles of macrosatellite repeats in genome organization and disease development

  • Dumbovic, Gabrijela
  • Forcales, Sònia Vanina|||0000-0002-7111-4959
  • Perucho, Manuel|||0000-0002-2169-2662
Abundant repetitive DNA sequences are an enigmatic part of the human genome. Despite increasing evidence on the functionality of DNA repeats, their biologic role is still elusive and under frequent debate. Macrosatellites are the largest of the tandem DNA repeats, located on one or multiple chromosomes. The contribution of macrosatellites to genome regulation and human health was demonstrated for the D4Z4 macrosatellite repeat array on chromosome 4q35. Reduced copy number of D4Z4 repeats is associated with local euchromatinization and the onset of facioscapulohumeral muscular dystrophy. Although the role other macrosatellite families may play remains rather obscure, their diverse functionalities within the genome are being gradually revealed. In this review, we will outline structural and functional features of coding and noncoding macrosatellite repeats, and highlight recent findings that bring these sequences into the spotlight of genome organization and disease development.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case- Control (MCC) Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Palazuelos, Camilo
  • Morros, Rosa|||0000-0001-6752-8748
  • Aragonés, Nuria
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Jiménez Monleón, Jose J.
  • Ruiz Cerdá, José Luis
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Ruiz-Dominguez, José Manuel
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Pollán, Marina|||0000-0002-4328-1565
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Llorca, Javier|||0000-0001-8569-861X
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in spain, A retrospective cohort study

  • Román, Marta|||0000-0001-9076-8918
  • Rué, Montserrat|||0000-0002-7862-9365
  • Sala, Maria|||0000-0002-9955-8746
  • Ascunce, Nieves
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Baroja, Araceli
  • la Vega Prieto, Mariola de|||0000-0003-3094-7898
  • Galceran, Jaume|||0000-0002-1584-7293
  • Natal, Carmen|||0000-0003-0204-3947
  • Salas, Dolores|||0000-0003-0064-1222
  • Sánchez Jacob, Mercedes
  • Zubizarreta Alberdi, Raquel
  • Castells, Xavier|||0000-0002-2528-0382
  • Blanch, Jordi|||0000-0003-2597-8454
  • Romero, Anabel
  • Almazán, Raquel
  • Fernández, Ana Belén
  • Queiro, María Teresa
  • Delfrade, Iosu
  • Ederra, María
  • Erdozain, Nieves
  • Vidán, Juana
  • Ibáñez, Josefa
  • Cuevas, Dolores
  • la Lastra, Isabel Díez de
  • González Román, Isabel
Background: Breast cancer incidence has decreased in the last decade, while the incidence of ductal carcinoma in situ (DCIS) has increased substantially in the western world. The phenomenon has been attributed to the widespread adaption of screening mammography. The aim of the study was to evaluate the temporal trends in the rates of screen detected invasive cancers and DCIS, and to compare the observed trends with respect to hormone replacement therapy (HRT) use along the same study period. Methods: Retrospective cohort study of 1,564,080 women aged 45-69 years who underwent 4,705,681 screening mammograms from 1992 to 2006. Age-adjusted rates of screen detected invasive cancer, DCIS, and HRT use were calculated for first and subsequent screenings. Poisson regression was used to evaluate the existence of a change-point in trend, and to estimate the adjusted trends in screen detected invasive breast cancer and DCIS over the study period. Results: The rates of screen detected invasive cancer per 100.000 screened women were 394.0 at first screening, and 229.9 at subsequent screen. The rates of screen detected DCIS per 100.000 screened women were 66.8 at first screen and 43.9 at subsequent screens. No evidence of a change point in trend in the rates of DCIS and invasive cancers over the study period were found. Screen detected DCIS increased at a steady 2.5% per year (95% CI: 1.3; 3.8), while invasive cancers were stable. Conclusion: Despite the observed decrease in breast cancer incidence in the population, the rates of screen detected invasive cancer remained stable during the study period. The proportion of DCIS among screen detected breast malignancies increased from 13% to 17% throughout the study period. The rates of screen detected invasive cancer and DCIS were independent of the decreasing trend in HRT use observed among screened women after 2002.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of sedatives and opioids on trigger and cycling asynchronies throughout mechanical ventilation, An observational study in a large dataset from critically ill patients

  • Haro López, Candelaria de|||0000-0002-2668-1030
  • Magrans, Rudys
  • López-Aguilar, Josefina|||0000-0003-2359-3980
  • Montanyà, Jaume
  • Lena, Enrico
  • Subirà, Carles|||0000-0003-2285-2311
  • Fernández-Gonzalo, Sol|||0000-0003-0267-0617
  • Gomà, Gemma|||0000-0002-1890-4855
  • Fernández, Rafael
  • Albaiceta, Guillermo M.|||0000-0002-9276-3253
  • Skrobik, Yoanna|||0000-0002-5315-6020
  • Lucangelo, Umberto
  • Murias, Gastón
  • Ochagavía Calvo, Ana|||0000-0002-0564-2913
  • Kacmarek, Robert M.
  • Rué, Montserrat|||0000-0002-7862-9365
  • Blanch, Lluís|||0000-0002-4158-7464
Background: In critically ill patients, poor patient-ventilator interaction may worsen outcomes. Although sedatives are often administered to improve comfort and facilitate ventilation, they can be deleterious. Whether opioids improve asynchronies with fewer negative effects is unknown. We hypothesized that opioids alone would improve asynchronies and result in more wakeful patients than sedatives alone or sedatives-plus-opioids. Methods: This prospective multicenter observational trial enrolled critically ill adults mechanically ventilated (MV).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

  • Ruiz de Porras, Vicenç|||0000-0002-4352-1784
  • Bystrup, Sara|||0000-0002-7971-0851
  • Cabrero de las Heras, Sara
  • Musulén, Eva|||0000-0002-9667-6464
  • Palomero, Luis|||0000-0002-9144-1017
  • Alonso, María Henar
  • Nieto Raya, Rocio|||0000-0001-8567-2268
  • Arango, Diego|||0000-0003-2953-3284
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Queralt, C.|||0000-0001-9875-0173
  • Manzano Mozo, José Luís
  • Layos, Laura
  • Bugés, Cristina|||0000-0003-2013-1510
  • Martínez Balibrea, Eva|||0000-0002-4501-7100
In recent years, an increasing number of studies have shown that elevated expression of cyclin dependent kinase (Cdk5) contributes to the oncogenic initiation and progression of many types of cancers. In this study, we investigated the expression pattern of Cdk5 in colorectal cancer (CRC) cell lines and in a large number of tumor samples in order to evaluate its relevance in this pathogenesis and possible use as a prognostic marker. We found that Cdk5 is highly expressed and activated in CRC cell lines and that silencing of the kinase decreases their migration ability. In tumor tissues, Cdk5 is overexpressed compared to normal tissues due to a copy number gain. In patients with localized disease, we found that high Cdk5 levels correlate with poor prognosis, while in the metastatic setting, this was only the case for patients receiving an oxaliplatin-based treatment. When exploring the Cdk5 levels in the consensus molecular subtypes (CMS), we found the lowest levels in subtype 1, where high Cdk5 again was associated with a poorer prognosis. In conclusion, we confirm that Cdk5 is involved in CRC and disease progression and that it could serve as a prognostic and predictive biomarker in this disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inflammatory mediators and dual depression, Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

  • García Marchena, Nuria|||0000-0002-0575-3613
  • Barrera-Conde, Marta|||0000-0002-0106-0000
  • Mestre-Pintó, Joan-Ignasi|||0000-0003-0387-9375
  • Araos, Pedro|||0000-0001-5172-8796
  • Serrano, Antonia
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Fonseca, Francina|||0000-0002-0779-6545
  • Ruiz, Juan Jesús
  • Rodríguez de Fonseca, Fernando|||0000-0002-4516-5795
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Pavón, Francisco Javier
  • Torrens, Marta
Major depressive disorder (MDD) is the most prevalent comorbid mental disorder among people with substance use disorders. The MDD can be both primary and substance-induced and its accurate diagnosis represents a challenge for clinical practice and treatment response. Recent studies reported alterations in the circulating expression of inflammatory mediators in patients with psychiatric disorders, including those related to substance use. The aim of the study was to explore TNF-α, IL-1β, CXCL12, CCL2, CCL11 (eotaxin-1) and CX3CL1 (fractalkine) as potential biomarkers to identify comorbid MDD and to distinguish primary MDD from substance-induced MDD in patients with substance disorders. Patients diagnosed with cocaine (CUD, n = 64) or alcohol (AUD, n = 65) use disorders with/without MDD were recruited from outpatient treatment programs [CUD/non-MDD (n = 31 CUD/primary MDD (n = 18 CUD/cocaine-induced MDD (N = 15 AUD/non-MDD (n = 27 AUD/primary MDD (n = 16) and AUD/alcohol-induced MDD (n = 22)]. Sixty-two healthy subjects were also recruited as control group. Substance and mental disorders were assessed according to "Diagnostic and Statistical Manual of Mental Disorders, 4 edition, text revision" (DSM-IV-TR) and a blood sample was collected for determinations in the plasma. The cocaine group showed lower TNF-α (p<0.05) and CCL11 (p<0.05), and higher IL-1β (p<0.01) concentrations than the control group. In contrast, the alcohol group showed higher IL-1β (p<0.01) and lower CXCL12 (p<0.01) concentrations than the control group. Regarding MDD, we only observed alterations in the cocaine group. Thus, CUD/MDD patients showed lower IL-1β (p<0.05), CXCL12 (p<0.05) and CCL11 (p<0.05), and higher CXC3CL1 (p<0.05) concentrations than CUD/non-MDD patients. Moreover, while CUD/primary MDD patients showed higher CCL11 (p<0.01) concentrations than both CUD/non-MDD and CUD/cocaine-induced MDD patients, CUD/cocaine-induced MDD patients showed lower CXCL12 (p<0.05) concentrations than CUD/non-MDD patients. Finally, a logistic regression model in the cocaine group identified CXCL12, CCL11 and sex to distinguish primary MDD from cocaine-induced MDD providing a high discriminatory power. The present data suggest an association between changes in inflammatory mediators and the diagnosis of primary and substance-induced MDD, namely in CUD patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM

  • Llauradó, Gemma|||0000-0002-3237-6366
  • Cano, Albert|||0000-0002-2804-3745
  • Albert Fàbregas, Lara|||0000-0003-3711-918X
  • Ballesta Purroy, Sílvia|||0000-0001-8057-1804
  • Mazarico, Isabel|||0000-0001-9651-7650
  • Luchtenberg, M. F.
  • González-Sastre, Montserrat
  • Megía, Ana|||0000-0002-5101-9452
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Vendrell, Joan|||0000-0002-6994-6115
  • González Clemente, José Miguel|||0000-0002-7409-8720
Objectives Currently used risk scores for type 2 diabetes mellitus (T2DM) clearly underestimate cardiovascular risk in type 1 diabetes (T1DM). Hence, there is a need to develop novel and specific risk-estimation tools for this population. We aimed to assess the relationship between the Steno Type 1 Risk Engine (ST1RE) and arterial stiffness (AS), and to identify potential cutoff points of interest in clinical practice. Design and methods A total of 179 patients with T1DM (50.8% men, mean age 41.2±13.1 years), without established cardiovascular disease, were evaluated for clinical and anthropometric data (including classical cardiovascular risk factors), and AS measured by aortic pulse-wave velocity (aPWV). The ST1RE was used to estimate 10-year cardiovascular risk and patients were classified into 3 groups: low- (<10%; n = 105), moderate- (10-20%; n = 53) and high-risk (≥20%; n = 21). Results When compared with the low- and moderate-risk groups, patients in the high-risk group were older, had higher prevalence of hypertension, dyslipidemia and insulin-resistance, and had higher body-mass index and HbA. aPWV increased in parallel with estimated cardiovascular risk (6.4±1.0, 8.4±1.3 and 10.3±2.6m/s; p<0.001). As an evaluation of model performance, the C-statistic of aPWV was 0.914 (95% confidence interval [CI]:0.873-0.950) for predicting moderate/high-risk and 0.879 (95%CI:0.809-0.948) for high-risk, according to the ST1RE. The best cut-off points of aPWV were 7.3m/s (sensitivity:86%, specificity:83%) and 8.7m/s (sensitivity:76%, specificity:86%) for moderate/high- and high-risk, respectively. Conclusions AS is highly correlated with the scores obtained from the ST1RE. We have identified two cut-off points of AS that can clearly discriminate moderate/high- and high-risk T1DM patients, which could be of great value in clinical practice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Variable phenotype in HNF1B mutations, extrarenal manifestations distinguish affected individuals from the population with congenital anomalies of the kidney and urinary tract

  • Madariaga, Leire|||0000-0002-4032-9842
  • García-Castaño, Alejandro|||0000-0002-9734-6600
  • Ariceta Iraola, Gema|||0000-0003-1763-1098
  • Martínez-Salazar, Rosa
  • Aguayo, Aníbal
  • Castaño, Luis|||0000-0003-0437-9401
Mutations in hepatocyte nuclear factor 1B (HNF1B) have been associated with congenital anomalies of the kidney and urinary tract (CAKUT) in humans. Diabetes and other less frequent anomalies have also been described. Variable penetrance and intrafamilial variability have been demonstrated including severe prenatal phenotypes. Thus, it is important to differentiate this entity from others with similar clinical features and perform confirmatory molecular diagnosis. This study reports the results of HNF1B screening in a cohort of 60 patients from 58 unrelated families presenting with renal structural anomalies and/or non-immune glucose metabolism alterations, and other minor features suggesting HNF1B mutations. This study identified a pathogenic variant in 23 patients from 21 families. The most frequent finding was bilateral cystic dysplasia or hyperechogenic kidneys (87% of patients). Sixty percent of them also fulfilled the criteria for impaired glucose metabolism, and these were significantly older than those patients with an HNF1B mutation but without diabetes or prediabetes (14.4 versus 3.3 years, P < 0.05). Furthermore, patients with HNF1B mutations had higher frequency of pancreatic structural anomalies and hypomagnesaemia than patients without mutations (P < 0.001 and P = 0.003, respectively). Hyperuricaemia and increased liver enzymes were detected in some patients as well. Renal anomalies found in patients with HNF1B mutations are frequently unspecific and may resemble those found in other renal pathologies (CAKUT, ciliopathies). Active searching for extrarenal minor features, especially pancreatic structural anomalies or hypomagnesaemia, could support the indication for molecular diagnosis to identify HNF1B mutations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tumour characteristics and survivorship in a cohort of breast cancer, the MCC-Spain study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos-Calderón, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Guevara, Marcela|||0000-0001-9242-6364
  • Molina de la Torre, Antonio José
  • Domingo, Laia|||0000-0003-4420-0891
  • Fernández-Ortiz, María|||0000-0003-0017-875X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Alguacil, Juan|||0000-0003-2703-9725
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Ibáñez, Josefa
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Diaz-Santos, Marian
  • Alonso, M. Henar
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Ardanaz, Eva
  • Molinuevo, Amaia
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased The online version of this article (10.1007/s10549-020-05600-x) contains supplementary material, which is available to authorised users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study)

  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Espinosa, Ana|||0000-0001-7399-3267
  • Castelló, Adela|||0000-0002-1308-9927
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Guevara, Marcela|||0000-0001-9242-6364
  • Martín, Vicente|||0000-0003-0552-2804
  • Amiano, Pilar
  • Alguacil, Juan|||0000-0003-2703-9725
  • Peiro, Rosana
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Costas, Laura
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Jimenez, Jose Juan
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Llorca, Javier|||0000-0001-8569-861X
  • Moreno-Iribas, Conchi|||0000-0001-6537-0131
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Oribe, Madalen
  • Aragonés, Nuria
  • Papantoniou, Kyriaki|||0000-0002-0340-9659
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Romaguera, Dora|||0000-0002-5762-8558
Modern life involves mistimed sleeping and eating patterns that in experimental studies are associated with adverse health effects. We assessed whether timing of meals is associated with breast and prostate cancer risk taking into account lifestyle and chronotype, a characteristic correlating with preference for morning or evening activity. We conducted a population-based case-control study in Spain, 2008-2013. In this analysis we included 621 cases of prostate and 1,205 of breast cancer and 872 male and 1,321 female population controls who had never worked night shift. Subjects were interviewed on timing of meals, sleep and chronotype and completed a Food Frequency Questionaire. Adherence to the World Cancer Research Fund/American Institute of Cancer Research recommendations for cancer prevention was examined. Compared with subjects sleeping immediately after supper, those sleeping two or more hours after supper had a 20% reduction in cancer risk for breast and prostate cancer combined (adjusted Odds Ratio [OR] = 0.80, 95%CI 0.67-0.96) and in each cancer individually (prostate cancer OR = 0.74, 0.55-0.99; breast cancer OR = 0.84, 0.67-1.06). A similar protection was observed in subjects having supper before 9 pm compared with supper after 10 pm. The effect of longer supper-sleep interval was more pronounced among subjects adhering to cancer prevention recommendations (OR both cancers= 0.65, 0.44-0.97) and in morning types (OR both cancers = 0.66, 0.49-0.90). Adherence to diurnal eating patterns and specifically a long interval between last meal and sleep are associated with a lower cancer risk, stressing the importance of evaluating timing in studies on diet and cancer. What's new? Evidence shows that long-term disruption of endogenous circadian rhythms may be associated with cancer. The effects of mistimed sleeping and eating patterns that come with modern life are however less clear. This large Spanish population-based study examined whether meal timing and sleep patterns are associated with the two most common nightshift-related cancers. Adherence to a more diurnal eating pattern, and specifically an early supper and a long interval between last meal and sleep were associated with a lower breast and prostate cancer risk, stressing the importance of evaluating circadian rhythms in diet and cancer studies and revisiting recommendations for prevention.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

  • López de Maturana, Evangelina
  • Rodríguez, Juan Antonio
  • Alonso, Lola|||0000-0002-3493-718X
  • Lao, Oscar
  • Molina Montes, Esther|||0000-0002-0428-2426
  • Martín-Antoniano, Isabel Adoración
  • Gómez-Rubio, Paulina
  • Lawlor, Rita
  • Carrato, Alfredo|||0000-0001-7749-8140
  • Hidalgo, Manuel|||0000-0002-3765-3318
  • Iglesias, Mar|||0000-0002-2274-4671
  • Molero, Xavier|||0000-0003-2473-7405
  • Löhr, Matthias
  • Michalski, Christopher
  • Perea, José
  • O'Rorke, Michael
  • Barberà, Victor Manuel
  • Tardón, Adonina|||0000-0001-5150-1209
  • Farré, Antoni|||0000-0003-1279-8868
  • Muñoz-Bellvis, Luis|||0000-0002-7809-5201
  • Crnogorac-Jurcevic, Tanja
  • Domínguez-Muñoz, Enrique
  • Gress, Thomas
  • Greenhalf, William
  • Sharp, Linda
  • Arnes, Luís
  • Cecchini, Lluís|||0000-0002-8873-0969
  • Balsells Valls, Joaquim|||0000-0002-1202-4136
  • Costello, Eithne
  • Ilzarbe, Lucas|||0000-0003-1798-6876
  • Kleeff, Jörg
  • Kong, Bo
  • Márquez, Mirari
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • O'Driscoll, Damian
  • Scarpa, Aldo
  • Ye, Weimin
  • Yu, Jingru
  • García-Closas, Montserrat
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Rothman, Nathaniel
  • Silverman, Debra T.
  • Albanes, Demetrius
  • Arslan, Alan A.
  • Beane-Freeman, Laura
  • Bracci, Paige M.
  • Brennan, Paul
  • Bueno-de-Mesquita, Bas
  • Buring, Julie
  • Canzian, Federico|||0000-0002-4261-4583
  • Du, Margaret
  • Gallinger, Steven
  • Gaziano, J. Michael
  • Goodman, Phyllis J.
  • Gunter, Marc
  • LeMarchand, Loic
  • Li, Donghui
  • Neale, Rachael E.
  • Peters, Ulrike
  • Petersen, Gloria M.
  • Risch, Harvey A.
  • Sánchez Pérez, María José|||0000-0003-4817-0757
  • Shu, Xiao-Ou
  • Thornquist, Mark D.
  • Visvanathan, Kala
  • Zheng, Wei|||0000-0003-1226-070X
  • Chanock, Stephen|||0000-0002-2324-3393
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Wolpin, Brian M.
  • Stolzenberg-Solomon, Rachael Z.
  • Klein, Alison P.
  • Amundadottir, Laufey T.|||0000-0003-1859-8971
  • Marti-Renom, Marc A.|||0000-0002-0151-4279
  • Real, Francisco X.|||0000-0001-9501-498X
  • Malats, Núria|||0000-0003-2538-3784
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance. We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants. We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E-06 in 1D approach and a Local Moran's Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8 -a lncRNA associated with pancreatic carcinogenesis-with a lowest p value = 6.91E-05. Importantly, two new PC loci were identified both by 2D and 3D approaches: SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1 -a major regulator of the ER stress and unfolded protein responses in acinar cells-identified by 3D; all of them with a strong in silico functional support. This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases. The online version contains supplementary material available at 10.1186/s13073-020-00816-4.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

  • Carrillo-Reixach, Juan|||0000-0002-8538-8264
  • Torrens, Laura
  • Simón-Coma, Marina
  • Royo, Laura|||0000-0001-5770-2001
  • Domingo-Sàbat, Montse|||0000-0001-6687-3259
  • Abril-Fornaguera, Jordi|||0000-0002-5871-4052
  • Akers, Nicholas
  • Sala Llinas, Margarita|||0000-0003-4879-1780
  • Ragull, Sonia
  • Arnal, Magdalena|||0000-0001-8647-9232
  • Villalmanzo, Núria
  • Cairo, Stefano
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Kappler, Roland
  • Garrido-Pontnou, Marta|||0000-0002-7762-7085
  • Guerra Pastrian, Laura|||0000-0002-8478-8522
  • Sábado, Constantino|||0000-0003-3956-5466
  • Guillén, Gabriela|||0000-0001-5632-2672
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Piñeyro, David|||0000-0001-5633-3339
  • Vázquez-Vitali, María
  • Kuchuk, Olga
  • Mateos, María Elena
  • Ramírez, Gema
  • López Santamaría, Manuel
  • Mozo, Yasmina
  • Soriano, Aroa|||0000-0001-9659-1471
  • Grotzer, Michael
  • Branchereau, Sophie
  • García de Andoin, Nagore
  • López-Ibor, Blanca
  • López-Almaraz, Ricardo
  • Salinas, José Antonio
  • Torres, Bárbara
  • Hernández, Francisco
  • Uriz, José Javier
  • Fabre, Monique
  • Blanco, Julià|||0000-0002-2225-0217
  • Paris, Claudia
  • Bajčiová, Viera
  • Laureys, Geneviève
  • Masnou, Helena|||0000-0003-0632-1393
  • Clos, Ariadna|||0000-0002-6414-2097
  • Beléndez, Cristina|||0000-0002-6019-6557
  • Guettier, Catherine
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Planas, Ramón
  • Jordà, Mireia|||0000-0003-3709-1850
  • Nonell, Lara|||0000-0002-8538-8213
  • Czauderna, Piotr
  • Morland, Bruce
  • Sia, Daniela|||0000-0002-9000-611X
  • Losic, Bojan
  • Buendia, Marie Annick
  • Sarrias, Maria-Rosa|||0000-0001-6929-8069
  • Llovet, Josep M.|||0000-0003-0547-2667
  • Armengol, Carolina|||0000-0002-4690-4027
Background & Aims: Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the predominant pediatric liver cancer, with limited therapeutic options for patients with aggressive tumors. Herein, we aimed to uncover the mechanisms of HB pathobiology and to identify new biomarkers and therapeutic targets in a move towards precision medicine for patients with advanced HB. Methods: We performed a comprehensive genomic, transcriptomic and epigenomic characterization of 159 clinically annotated samples from 113 patients with HB, using high-throughput technologies. Results: We discovered a widespread epigenetic footprint of HB that includes hyperediting of the tumor suppressor BLCAP concomitant with a genome-wide dysregulation of RNA editing and the overexpression of mainly non-coding genes of the oncogenic 14q32 DLK1-DIO3 locus. By unsupervised analysis, we identified 2 epigenomic clusters (Epi-CA, Epi-CB) with distinct degrees of DNA hypomethylation and CpG island hypermethylation that are associated with the C1/C2/C2B transcriptomic subtypes. Based on these findings, we defined the first molecular risk stratification of HB (MRS-HB), which encompasses 3 main prognostic categories and improves the current clinical risk stratification approach. The MRS-3 category (28%), defined by strong 14q32 locus expression and Epi-CB methylation features, was characterized by CTNNB1 and NFE2L2 mutations, a progenitor-like phenotype and clinical aggressiveness. Finally, we identified choline kinase alpha as a promising therapeutic target for intermediate and high-risk HBs, as its inhibition in HB cell lines and patient-derived xenografts strongly abrogated tumor growth. Conclusions: These findings provide a detailed insight into the molecular features of HB and could be used to improve current clinical stratification approaches and to develop treatments for patients with HB. Lay summary: Hepatoblastoma is a rare childhood liver cancer that has been understudied. We have used cutting-edge technologies to expand our molecular knowledge of this cancer. Our biological findings can be used to improve clinical management and pave the way for the development of novel therapies for this cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Thenar oxygen saturation (StO) alterations during a spontaneous breathing trial predict extubation failure

  • Mesquida Febrer, Jaume|||0000-0003-3670-5021
  • Gruartmoner de Vera, Guillem|||0000-0001-8414-5845
  • Espinal, Cristina|||0000-0001-8701-9983
  • Masip, Jordi
  • Sabatier, Caroline
  • Villagrá, Ana
  • Gómez, Hernando
  • Pinsky, Michael
  • Baigorri, Francisco
  • Artigas Raventós, Antoni|||0000-0002-8029-1017
Weaning from mechanical ventilation (MV) is a cardiovascular stress test. Monitoring the regional oxygenation status has shown promising results in predicting the tolerance to spontaneously breathe in the process of weaning from MV. Our aim was to determine whether changes in skeletal muscle oxygen saturation (StO) measured by near-infrared spectroscopy (NIRS) on the thenar eminence during a vascular occlusion test (VOT) can be used to predict extubation failure from mechanical ventilation. We prospectively studied 206 adult patients with acute respiratory failure receiving MV for at least 48 h from a 30-bed mixed ICU, who were deemed ready to wean by their physicians. Patients underwent a 30-min spontaneous breathing trial (SBT), and were extubated according to the local protocol. Continuous StO was measured non-invasively on the thenar eminence. A VOT was performed prior to and at 30 min of the SBT (SBT). The rate of StO deoxygenation (DeO), StO reoxygenation (ReO) rate and StO hyperemic response to ischemia (H ) were calculated. Thirty-six of the 206 patients (17%) failed their SBT. The remainder 170 patients (83%) were extubated. Twenty-three of these patients (13.5%) needed reinstitution of MV within 24 h. Reintubated patients displayed a lower H at baseline, and higher relative changes in their StO deoxygenation rate between baseline and SBT (DeO Ratio). A logistic regression-derived StO score, combining baseline StO, H and DeO ratio, showed an AUC of 0.84 (95% CI 0.74-0.91) for prediction of extubation failure. Extubation failure was associated to baseline and dynamic StO alterations during the SBT. Monitoring StO-derived parameters might be useful in predicting extubation outcome.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dietary Constituents, Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Gutiérrez-Ruiz, Nuria
  • Aragonés, Nuria
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Guevara, Marcela|||0000-0001-9242-6364
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Alguacil, Juan|||0000-0003-2703-9725
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Rodríguez-Cundín, Paz
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Canseco Fernandez, Rosario
  • Castilla, Jesus|||0000-0002-6396-7265
  • Molinuevo, Amaia
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed up. Information about their dietary habits before diagnosis was collected using a semi-quantitative Food Frequency Questionnaire. Participants without FFQ or with implausible energy intake were excluded. The total amount consumed of each nutrient (Kcal/day) was divided into tertiles, considering as "high intakes" those above third tertile. The main effect studied was overall survival. Cox regression was used to assess the association between death and nutrient intake. During a median follow-up of 6.5 years, 171 deaths were observed. None of the nutrients analysed was associated with mortality in the whole sample. However, in normal-weight women (BMI 18.5-25 kg/m 2) a high intake of carbohydrates (≥809 Kcal/day), specifically monosaccharides (≥468 Kcal/day), worsened prognostic compared to lowest (≤352 Kcal/day). Hazard Ratios (HRs) for increasing tertiles of intake were HR:2.22 95% CI (1.04 to 4.72) and HR:2.59 95% CI (1.04 to 6.48), respectively (p trend = 0.04)). Conversely, high intakes of polyunsaturated fats (≥135 Kcal/day) improved global survival (HR: 0.39 95% CI (0.15 to 1.02) p -trend = 0.05) compared to the lowest (≤92.8 kcal/day). In addition, a protective effect was found substituting 100 kcal of carbohydrates with 100 kcal of fats in normal-weight women (HR: 0.76 95% CI (0.59 to 0.98)). Likewise, in premenopausal women a high intake of fats (≥811 Kcal/day) showed a protective effect (HR:0.20 95% CI (0.04 to 0.98) p trend = 0.06). Finally, in Estrogen Receptors (ER) negative tumors, we found a protective effect of high intake of animal proteins (≥238 Kcal/day, HR: 0.24 95% CI (0.06 to 0.98). According to our results, menopausal status, BMI and ER status could play a role in the relationship between diet and BC survival and must be taken into account when studying the influence of different nutrients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validating a breast cancer score in Spanish women. The MCC-Spain study

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Palazuelos, Camilo
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Altzibar, Jone M.
  • González-Donquiles, Carmen
  • Ardanaz, Eva
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Vidal, Carmen|||0000-0003-2768-2710
  • Bayo-Calero, Juan
  • Tardón, Adonina|||0000-0001-5150-1209
  • Salas, Dolores|||0000-0003-0064-1222
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Morros, Rosa|||0000-0001-6752-8748
  • Rodriguez-Cundin, Paz
  • Vinyals, Gemma Castaño
  • Ederra, María
  • Vilorio-Marqués, Laura
  • Amiano, Pilar
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, 1,732 breast cancer cases and 1,910 controls were studied. The GRS92, modifiable and non-modifiable risk factor scores were estimated via logistic regression. SNPs without available genotyping were simulated as in the aforementioned 2016 study. The full model score was obtained by combining GRS92, modifiable and non-modifiable risk factor scores. Score performances were tested via the area under the ROC curve (AUROC), net reclassification index (NRI) and integrated discrimination improvement (IDI). Compared with non-modifiable and modifiable factor scores, GRS92 had higher discrimination power (AUROC: 0.6195, 0.5885 and 0.5214, respectively). Adding the non-modifiable factor score to GRS92 improved patient classification by 23.6% (NRI = 0.236), while the modifiable factor score only improved it by 7.2%. The full model AUROC reached 0.6244. A simulation study showed the ability of the full model for identifying women at high risk for breast cancer. In conclusion, a model combining genetic and risk factors can be used for stratifying women by their breast cancer risk, which can be applied to individualizing genetic counseling and screening recommendations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Predicting Patient-ventilator Asynchronies with Hidden Markov Models

  • Marchuk, Yaroslav
  • Magrans, Rudys
  • Sales, Bernat
  • Montanya, Jaume
  • López-Aguilar, Josefina|||0000-0003-2359-3980
  • Haro López, Candelaria de|||0000-0002-2668-1030
  • Gomà, Gemma|||0000-0002-1890-4855
  • Subirà, Carles|||0000-0003-2285-2311
  • Fernández, Rafael
  • Kacmarek, Robert M.
  • Blanch, Lluís|||0000-0002-4158-7464
In mechanical ventilation, it is paramount to ensure the patient's ventilatory demand is met while minimizing asynchronies. We aimed to develop a model to predict the likelihood of asynchronies occurring. We analyzed 10,409,357 breaths from 51 critically ill patients who underwent mechanical ventilation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Resveratrol Increases Hepatic SHBG Expression through Human Constitutive Androstane Receptor, a new Contribution to the French Paradox

  • Saez-Lopez, Cristina
  • Brianso-Llort, Laura|||0000-0002-5650-8503
  • Torres-Torrenteras, Javier
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Hammond, Geoffrey L.
  • Martínez Selva, David|||0000-0002-0333-5629
Sex hormone-binding globulin (SHBG) carries sex steroids in blood regulating their bioavailability. Red wine consumption increases plasma SHBG levels, and we have discovered that resveratrol, a polyphenol enriched in red wine, acts specifically through the human constitutive androstane receptor (CAR), a drug/xenobiotic detoxification gene regulator, to increase hepatic SHBG production. Chromatin immunoprecipitation and luciferase reporter gene assays show that human CAR binds to a typical direct repeat 1 nuclear hormone receptor-binding element in the human SHBG proximal promoter. Resveratrol also increased hepatic SHBG production in humanized SHBG / CAR transgenic mice. Moreover, SHBG expression correlated significantly with CAR mRNA levels in human liver biopsies. We conclude that the beneficial effects of red wine on the metabolic syndrome and it associated co-morbidities, including cardiovascular disease and type 2 diabetes, may be mediated in part by resveratrol acting via CAR to increase plasma SHBG levels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ancient Haplotypes at the 15q24.2 Microdeletion Region Are Linked to Brain Expression of MAN2C1 and Children's Intelligence

  • Cáceres, Alejandro|||0000-0001-8551-6695
  • Esko, Tõnu
  • Pappa, Irene
  • Gutiérrez, Armand
  • Lopez-Espinosa, Maria-Jose
  • Llop, Sabrina
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Tiemeier, Henning|||0000-0002-4395-1397
  • Metspalu, Andres|||0000-0002-3718-796X
  • Joshi, Peter K.|||0000-0002-6361-5059
  • Wilsonx, James F.
  • Reina-Castillón, Judith
  • Shin, Jean|||0000-0001-7353-5178
  • Pausova, Zdenka
  • Paus, Tomáš
  • Sunyer, Jordi
  • Pérez-Jurado, Luis Alberto|||0000-0002-1988-3005
  • González, Juan R.|||0000-0003-3267-2146
The chromosome bands 15q24.1-15q24.3 contain a complex region with numerous segmental duplications that predispose to regional microduplications and microdeletions, both of which have been linked to intellectual disability, speech delay and autistic features. The region may also harbour common inversion polymorphisms whose functional and phenotypic manifestations are unknown. Using single nucleotide polymorphism (SNP) data, we detected four large contiguous haplotype-genotypes at 15q24 with Mendelian inheritance in 2,562 trios, African origin, high population stratification and reduced recombination rates. Although the haplotype-genotypes have been most likely generated by decreased or absent recombination among them, we could not confirm that they were the product of inversion polymorphisms in the region. One of the blocks was composed of three haplotype-genotypes (N1a, N1b and N2), which significantly correlated with intelligence quotient (IQ) in 2,735 children of European ancestry from three independent population cohorts. Homozygosity for N2 was associated with lower verbal IQ (2.4-point loss, p-value = 0.01), while homozygosity for N1b was associated with 3.2-point loss in non-verbal IQ (p-value = 0.0006). The three alleles strongly correlated with expression levels of MAN2C1 and SNUPN in blood and brain. Homozygosity for N2 correlated with over-expression of MAN2C1 over many brain areas but the occipital cortex where N1b homozygous highly under-expressed. Our population-based analyses suggest that MAN2C1 may contribute to the verbal difficulties observed in microduplications and to the intellectual disability of microdeletion syndromes, whose characteristic dosage increment and removal may affect different brain areas.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population, The MCC-Spain Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Lope, Virginia
  • Tusquets, Ignasi
  • Alonso, María Henar
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Barricarte, Aurelio
  • Tardón, Adonina|||0000-0001-5150-1209
  • Camacho, Antonio
  • Peiro-Perez, Rosana
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Muñoz, Montse
  • Michelena-Echeveste, Maria Jesus
  • Ortega Valin, Luis
  • Guevara, Marcela|||0000-0001-9242-6364
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers. In this case-control study, we report the antihypertensive drugs-breast cancer relationship in 1,736 breast cancer cases and 1,895 healthy controls; results are reported stratifying by the women's characteristics (i.e., menopausal status or body mass index category) tumor characteristics and length of use of antihypertensive drugs. The relationship among breast cancer and use of calcium channel blockers (CCB) for 5 or more years had odds ratio (OR) = 1.77 (95% CI, 0.99 to 3.17). Stratifying by BMI, the OR increased significantly in the group with BMI ≥ 25 (OR 2.54, 95% CI, 1.24 to 5.22). CCBs were even more strongly associated with more aggressive tumors, (OR for invasive tumors = 1.96, 95% CI = 1.09 to 3.53; OR for non ductal cancers = 3.97, 95% CI = 1.73 to 9.05; OR for Erbb2+ cancer = 2.97, 95% CI: 1.20 to 7.32). On the other hand, premenopausal women were the only group in which angiotensin II receptor blockers may be associated with breast cancer (OR = 4.27, 95% CI = 1.32 to 13.84) but this could not be identified with any type or stage. Use of angiotensin-converting-enzyme inhibitors, beta blockers and diuretics were not associated with risk. In this large population-based study we found that long term use of calcium channel blockers is associated with some subtypes of breast cancer (and with breast cancer in overweight women).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Automatic detection of ventilatory modes during invasive mechanical ventilation

  • Murias, Gastón
  • Montanyà, Jaume
  • Chacón, Encarna
  • Estruga, Anna
  • Subirà, Carles|||0000-0003-2285-2311
  • Fernández, Rafael
  • Sales, Bernat
  • Haro López, Candelaria de|||0000-0002-2668-1030
  • López-Aguilar, Josefina|||0000-0003-2359-3980
  • Lucangelo, Umberto
  • Villar, Jesús
  • Kacmarek, Robert M.
  • Blanch, Lluís|||0000-0002-4158-7464
Expert systems can help alleviate problems related to the shortage of human resources in critical care, offering expert advice in complex situations. Expert systems use contextual information to provide advice to staff. In mechanical ventilation, it is crucial for an expert system to be able to determine the ventilatory mode in use. Different manufacturers have assigned different names to similar or even identical ventilatory modes so an expert system should be able to detect the ventilatory mode. The aim of this study is to evaluate the accuracy of an algorithm to detect the ventilatory mode in use. We compared the results of a two-step algorithm designed to identify seven ventilatory modes. The algorithm was built into a software platform (BetterCare® system, Better Care SL; Barcelona, Spain) that acquires ventilatory signals through the data port of mechanical ventilators. The sample analyzed compared data from consecutive adult patients who underwent.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer, The Spanish Multi-Case-control (MCC) study

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • de Pedro, María
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Servitja, Sonia|||0000-0001-6988-4519
  • Morros, Rosa|||0000-0001-6752-8748
  • Amiano, Pilar
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Barricarte, Aurelio
  • Tardón, Adonina|||0000-0001-5150-1209
  • Diaz-Santos, Marian
  • Peiro-Perez, Rosana
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Lope, Virginia
  • Gracia-Lavedan, Esther
  • Alonso, M. Henar
  • Michelena-Echeveste, Maria Jesus
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Guevara, Marcela|||0000-0001-9242-6364
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The relationship between non-steroidal anti-inflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers. The online version of this article (doi:10.1186/s12885-016-2692-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An original phylogenetic approach identified mitochondrial haplogrou,p T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

  • Blein, Sophie
  • Bardel, Claire
  • Danjean, Vincent
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Healey, Sue
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Lee, Andrew
  • Dennis, Joe|||0000-0003-4591-1214
  • Kuchenbaecker, Karoline B.
  • Soucy, Penny
  • Terry, Mary Beth
  • Chung, Wendy
  • Goldgar, David E.
  • Buys, Saundra|||0000-0003-4120-5697
  • Janavicius, Ramunas
  • Tihomirova, Laima
  • Tung, Nadine
  • Dorfling, Cecilia M.
  • van Rensburg, Elizabeth J.|||0000-0003-2077-230X
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Ding, Yuan Chun
  • Gerdes, Anne-Marie
  • Ejlertsen, Bent
  • Nielsen, Finn C.
  • Hansen, Thomas V. O.
  • Osorio, Ana|||0000-0001-8124-3984
  • Benitez, Javier|||0000-0002-0923-7202
  • Andrés Conejero, Raquel
  • Segota, Ena
  • Weitzel, Jeffrey N.
  • Thelander, Margo
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Radice, Paolo|||0000-0001-6298-4111
  • Pensotti, Valeria
  • Dolcetti, Riccardo
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Peissel, Bernard|||0000-0001-9233-3571
  • Zaffaroni, Daniela|||0000-0002-6995-2216
  • Scuvera, Giulietta
  • Manoukian, Siranoush
  • Varesco, Liliana
  • Capone, Gabriele L.
  • Papi, Laura
  • Ottini, Laura
  • Yannoukakos, Drakoulis
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Garber, Judy
  • Hamann, Ute|||0000-0001-6705-7624
  • Donaldson, Alan|||0000-0001-9193-4172
  • Brady, Angela
  • Brewer, Carole
  • Foo, Claire
  • Evans, Gareth|||0000-0002-8482-5784
  • Frost, Debra
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Cook, Jackie
  • Adlard, Julian|||0000-0002-1693-0435
  • Barwell, Julian
  • Walker, Lisa
  • Izatt, Louise|||0000-0003-1258-4843
  • Side, Lucy E.
  • Kennedy, M. John
  • Tischkowitz, Marc
  • Rogers, Mark T.
  • Porteous, Mary E.
  • Morrison, Patrick J.
  • Platte, Radka
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Davidson, Rosemarie
  • Hodgson, Shirley
  • Cole, Trevor
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Isaacs, Claudine|||0000-0002-9646-1260
  • Claes, Kathleen|||0000-0003-0841-7372
  • De Leeneer, Kim
  • Meindl, Alfons
  • Gehrig, Andrea
  • Wappenschmidt, Barbara
  • Sutter, Christian|||0000-0003-4051-5888
  • Engel, Christoph
  • Niederacher, Dieter
  • Steinemann, Doris|||0000-0001-8797-0816
  • Plendl, Hansjoerg
  • Kast, Karin|||0000-0001-6531-755X
  • Rhiem, Kerstin
  • Ditsch, Nina
  • Arnold, Norbert
  • Varon-Mateeva, Raymonda
  • Schmutzler, Rita K.
  • Preisler-Adams, Sabine
  • Markov, Nadja Bogdanova
  • Wang-Gohrke, Shan
  • De Pauw, Antoine|||0000-0003-3898-073X
  • Lefol, Cédrick
  • Lasset, Christine
  • Leroux, Dominique
  • Rouleau, Etienne
  • Damiola, Francesca
  • Dreyfus, Hélène
  • Barjhoux, Laure
  • Golmard, Lisa
  • Uhrhammer, Nancy
  • Bonadona, Valérie
  • Sornin, Valérie
  • Bignon, Yves-Jean
  • Carter, Jonathan
  • Van Le, Linda
  • Piedmonte, Marion
  • DiSilvestro, Paul A.
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • Caldes, Trinidad
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Aittomäki, Kristiina
  • Jager, Agnes
  • van den Ouweland, Ans M. W.
  • Kets, Carolien M.
  • Aalfs, Cora M.
  • van Leeuwen, Flora E.
  • Hogervorst, Frans B. L.
  • Meijers-Heijboer, Hanne E. J.
  • Oosterwijk, Jan C.
  • van Roozendaal, Kees E. P.
  • Rookus, Matti A.
  • Devilee, Peter|||0000-0002-8023-2009
  • van der Luijt, Rob B.
  • Olah, Edith
  • Diez, Orland|||0000-0001-7339-0570
  • Teule, Alex|||0000-0003-0028-7200
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Sukiennicki, Grzegorz
  • Gronwald, Jacek
  • Lubinski, Jan|||0000-0003-2931-3003
  • Durda, Katarzyna
  • Jaworska-Bieniek, Katarzyna
  • Agnarsson, Bjarni A.
  • Maugard, Christine
  • Amadori, Alberto
  • Montagna, Marco
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Spurdle, Amanda B.
  • Foulkes, William|||0000-0001-7427-4651
  • Olswold, Curtis
  • Lindor, Noralane M.
  • Pankratz, Vernon S.
  • Szabo, Csilla I.
  • Lincoln, Anne
  • Jacobs, Lauren
  • Corines, Marina|||0000-0001-8472-4046
  • Robson, Mark
  • Vijai, Joseph
  • Berger, Andreas|||0000-0001-5865-6609
  • Fink-Retter, Anneliese
  • Singer, Christian F.
  • Rappaport, Christine
  • Kaulich, Daphne Geschwantler
  • Pfeiler, Georg
  • Tea, Muy-Kheng
  • Greene, Mark H.|||0000-0003-1852-9239
  • Mai, Phuong L.
  • Rennert, Gad|||0000-0002-8512-068X
  • Imyanitov, Evgeny N.
  • Mulligan, Anna Marie
  • Glendon, Gord
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Tchatchou, Sandrine
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Pedersen, Inge Sokilde
  • Thomassen, Mads
  • Kruse, Torben A.
  • Jensen, Uffe Birk
  • Caligo, Maria|||0000-0003-0589-1829
  • Friedman, Eitan|||0000-0002-6745-1733
  • Zidan, Jamal
  • Laitman, Yael
  • Lindblom, Annika
  • Melin, Beatrice
  • Arver, Brita
  • Loman, Niklas
  • Rosenquist, Richard|||0000-0002-0211-8788
  • Olopade, Olufunmilayo I.|||0000-0002-9936-1599
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Ramus, Susan J.|||0000-0003-0005-7798
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Rebbeck, Timothy R.
  • Arun, Banu K.
  • Mitchell, Gillian
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Lester, Jenny
  • Orsulic, Sandra|||0000-0001-5119-8721
  • Stoppa-Lyonnet, Dominique
  • Thomas, Gilles
  • Simard, Jacques|||0000-0001-6906-3390
  • Couch, Fergus J.
  • Offit, Kenneth
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Chenevix-Trench, Georgia
  • Antoniou, Antonis C.
  • Mazoyer, Sylvie
  • Phelan, Catherine M.
  • Sinilnikova, Olga M.
  • Cox, David G.
Individuals carrying pathogenic mutations in the BRCA1 and BRCA2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double-strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals with different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. In the present study, we tested the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers. We genotyped 22,214 (11,421 affected, 10,793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched in affected or unaffected individuals. We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers compared with the rest of clade T (hazard ratio (HR) = 0.55; 95% confidence interval (CI), 0.34 to 0.88; P = 0.01). Compared with the most frequent haplogroup in the general population (that is, H and T clades), the T1a1 haplogroup has a HR of 0.62 (95% CI, 0.40 to 0.95; P = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk. This study illustrates how original approaches such as the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects. The online version of this article (doi:10.1186/s13058-015-0567-2) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of Risk Factors on Different Interval Cancer Subtypes in a Population-Based Breast Cancer Screening Programme

  • Blanch, Jordi|||0000-0001-8211-3292
  • Sala, Maria|||0000-0002-9955-8746
  • Ibáñez, Josefa
  • Domingo, Laia|||0000-0003-4420-0891
  • Fernandez, Belén
  • Otegi, Arantza
  • Barata, Teresa
  • Zubizarreta Alberdi, Raquel
  • Ferrer, Joana
  • Castells, Xavier|||0000-0002-2528-0382
  • Rué, Montserrat|||0000-0002-7862-9365
  • Salas, Dolores|||0000-0003-0064-1222
Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes and to compare the risk factors identified with those associated with incident screen-detected cancers. We analyzed data from 645,764 women participating in the Spanish breast cancer screening program from 2000-2006 and followed-up until 2009. A total of 5,309 screen-detected and 1,653 interval cancers were diagnosed. Among the latter, 1,012 could be classified on the basis of findings in screening and diagnostic mammograms, consisting of 489 true interval cancers (48.2%), 235 false-negatives (23.2%), 172 minimal-signs (17.2%) and 114 occult tumors (11.3%). Information on the screening protocol and women's characteristics were obtained from the screening program registry. Cause-specific Cox regression models were used to estimate the hazard ratios (HR) of risks factors for interval cancer and incident screen-detected cancer. A multinomial regression model, using screen-detected tumors as a reference group, was used to assess the effect of breast density and other factors on the occurrence of interval cancer subtypes. A previous false-positive was the main risk factor for interval cancer (HR = 2.71, 95%CI: 2.28-3.23); this risk was higher for false-negatives (HR = 8.79, 95%CI: 6.24-12.40) than for true interval cancer (HR = 2.26, 95%CI: 1.59-3.21). A family history of breast cancer was associated with true intervals (HR = 2.11, 95%CI: 1.60-2.78), previous benign biopsy with a false-negatives (HR = 1.83, 95%CI: 1.23-2.71). High breast density was mainly associated with occult tumors (RRR = 4.92, 95%CI: 2.58-9.38), followed by true intervals (RRR = 1.67, 95%CI: 1.18-2.36) and false-negatives (RRR = 1.58, 95%CI: 1.00-2.49). The role of women's characteristics differs among interval cancer subtypes. This information could be useful to improve effectiveness of breast cancer screening programmes and to better classify subgroups of women with different risks of developing cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy

  • Gallardo, Eduard|||0000-0002-3942-3436
  • Luna Salva, Noemí de|||0000-0002-4342-794X
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Flix, Bàrbara|||0000-0002-4731-7801
  • de Morrée, Antoine
  • van der Maarel, Silvère
  • Illa, Isabel|||0000-0002-2186-2684
Dysferlinopathies are caused by mutations in the dysferlin gene (DYSF). Diagnosis is complex due to the high clinical variability of the disease and because dysferlin expression in the muscle biopsy may be secondarily reduced due to a primary defect in some other gene. Dysferlin is also expressed in peripheral blood monocytes (PBM). Studying dysferlin in monocytes is used for the diagnosis of dysferlin myopathies. The aim of the study was to determine whether dysferlin expression in PBM correlates with that in skeletal muscle. Using western-blot (WB) we quantified dysferlin expression in PBM from 21 pathological controls with other myopathies in whom mutations in DYSF were excluded and from 17 patients who had dysferlinopathy and two mutations in DYSF. Results were compared with protein expression in muscle by WB and immunohistochemistry (IH). We found a good correlation between skeletal muscle and monocytes using WB. However, IH results were misleading because abnormal expression of dysferlin was also observed in 13/21 pathological controls. The analysis of dysferlin protein expression in PBM is helpful when: 1) the skeletal muscle IH pattern is abnormal or 2) when muscle WB can not be performed either because muscle sample is lacking or insufficient or because the muscle biopsy is taken from a muscle at an end-stage and it mainly consists of fat and fibrotic tissue.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Translational Relevance of Human Circulating Memory Cutaneous Lymphocyte-Associated Antigen Positive T Cells in Inflammatory Skin Disorders

  • de Jesús-Gil, Carmen
  • Sans-de SanNicolàs, Lídia
  • García-Jiménez, Irene|||0000-0002-1769-354X
  • Ferran, Marta|||0000-0003-1198-0641
  • Celada, Antonio
  • Chiriac, Anca
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Santamaria-Babí, Luis F.|||0000-0002-1674-6654
Circulating memory T cells are heterogeneous in their tissue tropism. The skin-seeking T cell subset expresses the cutaneous lymphocyte-associated antigen (CLA) on their surface. CLA + memory T cells not only migrate from blood to skin but also recirculate between blood and skin. Studying CLA + memory T cells in cutaneous diseases has allowed a better understanding of immune-inflammatory mechanisms that take place. The analysis of the phenotypical features of these cells, their antigen specificity, cytokine production profile, and changes in relationship to clinical status and therapies among other characteristics have led to the concept that they constitute peripheral cellular biomarkers in T cell-mediated cutaneous conditions. CLA + memory T cells are of relevance in the pathogenesis of several cutaneous diseases, such as psoriasis (PSO), atopic dermatitis, vitiligo, and drug-induced allergic reactions, to name a few. The interaction of circulating CLA + T cells with skin-resident cells has been investigated in different ex vivo coculture models made out of clinical samples. Interestingly, microbes that are present in the skin or related with human skin diseases are preferentially recognized by CLA + T cells. Thus, the interaction of Streptococcus pyogenes with CLA + T cells in PSO is providing novel concepts that help to understand disease immunopathogenesis. The goal of this review is to present latest results in the field of CLA + T cells in T cell-mediated inflammatory skin diseases and their translational relevance for human immunodermatology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood flow response to orthostatic challenge identifies signatures of the failure of static cerebral autoregulation in patients with cerebrovascular disease

  • Gregori-Pla, Clara|||0000-0002-6623-0031
  • Mesquita, Rickson C.
  • Favilla, Christopher G.
  • Busch, David R.
  • Blanco, Igor|||0000-0001-7636-1177
  • Zirak, Peyman|||0000-0002-0331-6292
  • Frisk, Lisa Kobayashi
  • Avtzi, Stella|||0000-0002-8893-3969
  • Maruccia, Federica|||0000-0002-3774-7875
  • Giacalone, Giacomo
  • Cotta, Gianluca
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Mullen, Michael T.
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Prats Sánchez, Luis Antonio|||0000-0002-3192-4631
  • Martínez-Domeño, Alejandro|||0000-0002-9933-3192
  • Kasner, Scott E.
  • Greenberg, Joel H.
  • Zhou, Chao
  • Edlow, Brian L.
  • Putt, Mary E.
  • Detre, John A.
  • Yodh, Arjun G.
  • Durduran, Turgut|||0000-0001-5838-1027
  • Delgado Mederos, Raquel|||0000-0003-3737-7226
The cortical microvascular cerebral blood flow response (CBF) to different changes in head-of-bed (HOB) position has been shown to be altered in acute ischemic stroke (AIS) by diffuse correlation spectroscopy (DCS) technique. However, the relationship between these relative ΔCBF changes and associated systemic blood pressure changes has not been studied, even though blood pressure is a major driver of cerebral blood flow. Transcranial DCS data from four studies measuring bilateral frontal microvascular cerebral blood flow in healthy controls (n = 15), patients with asymptomatic severe internal carotid artery stenosis (ICA, n = 27), and patients with acute ischemic stroke (AIS, n = 72) were aggregated. DCS-measured CBF was measured in response to a short head-of-bed (HOB) position manipulation protocol (supine/elevated/supine, 5 min at each position). In a sub-group (AIS, n = 26; ICA, n = 14; control, n = 15), mean arterial pressure (MAP) was measured dynamically during the protocol. After elevated positioning, DCS CBF returned to baseline supine values in controls (p = 0.890) but not in patients with AIS (9.6% [6.0,13.3], mean 95% CI, p < 0.001) or ICA stenosis (8.6% [3.1,14.0], p = 0.003)). MAP in AIS patients did not return to baseline values (2.6 mmHg [0.5, 4.7], p = 0.018), but in ICA stenosis patients and controls did. Instead ipsilesional but not contralesional CBF was correlated with MAP (AIS 6.0%/mmHg [- 2.4,14.3], p = 0.038; ICA stenosis 11.0%/mmHg [2.4,19.5], p < 0.001). The observed associations between ipsilateral CBF and MAP suggest that short HOB position changes may elicit deficits in cerebral autoregulation in cerebrovascular disorders. Additional research is required to further characterize this phenomenon. The online version contains supplementary material available at 10.1186/s12883-021-02179-8.
Dipòsit Digital de Documents de la UAB
Publicación Capítulo o parte de un libro (BookPart)

Back to Front Architecture for Diagnosis as a Service

  • Sánchez Ramos, Carles|||0000-0003-3435-9882
  • Viñas, Miguel-Angel
  • Atens, Coen Jacobus
  • Borràs, Agnés|||0000-0002-7747-9924
  • Gil, Debora|||0000-0002-2770-4767
Software as a Service (SaaS) is a cloud computing model in which a provider hosts applications in a server that customers use via internet. Since SaaS does not require to install applications on customers' own computers, it allows the use by multiple users of highly specialized software without extra expenses for hardware acquisition or licensing. A SaaS tailored for clinical needs not only would alleviate licensing costs, but also would facilitate easy access to new methods for diagnosis assistance. This paper presents a SaaS client-server architecture for Diagnosis as a Service (DaaS). The server is based on docker technology in order to allow execution of softwares implemented in different languages with the highest portability and scalability. The client is a content management system allowing the design of websites with multimedia content and interactive visualization of results allowing user editing. We explain a usage case that uses our DaaS as crowdsourcing platform in a multicentric pilot study carried out to evaluate the clinical benefits of a software for assessment of central airway obstruction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression

  • Fonseca, Francina|||0000-0002-0779-6545
  • Mestre-Pintó, Joan-Ignasi|||0000-0003-0387-9375
  • Rodríguez-Minguela, Rocío
  • Papaseit, Esther|||0000-0003-2620-4274
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Langohr, Klaus|||0000-0001-7075-9192
  • Barbuti, Margherita
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torrens, Marta
Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence of medical comorbidities. The aim of this study is to investigate differences in brain derived neurotrophic factor (BDNF) and cortisol plasmatic levels in patients diagnosed with CUD-primary-MDD and CUD-induced-MDD and also to compare them to a sample of MDD patients (without cocaine use), a sample of CUD (without MDD), and a group of healthy controls (HC) after a stress challenge. A total of 46 subjects were included: MDD (n = 6), CUD (n = 15), CUD-primary-MDD (n = 16), CUD-induced-MDD (n = 9), and 21 HC. Psychiatric comorbidity was assessed with the Spanish version of the Psychiatric Research Interview for Substance and Mental Disorders IV (PRISM-IV), and depression severity was measured with the Hamilton Depression Rating Scale (HDRS). Patients were administered the Trier Social Stress Test (TSST) before and after the biological measures, including BDNF, and cortisol levels were obtained. After the TSST, Cohen's d values between CUD-primary-MDD and CUD-induced-MDD increased in each assessment from 0.19 post-TSST to 2.04 post-90-TSST. Pairwise differences among CUD-induced-MDD and both MDD and HC groups had also a large effect size value in post-30-TSST and post-90-TSST. In the case of the BDNF concentrations, CUD-primary-MDD and CUD-induced-MDD in post-90-TSST (12,627.27 ± 5488.09 vs.17,144.84 ± 6581.06, respectively) had a large effect size (0.77). Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Three-year follow-up of the poiba intervention on childhood obesity, A quasi-experimental study

  • Sánchez-Martínez, Francesca|||0000-0001-8198-1661
  • Brugueras Torrella, Silvia|||0000-0001-6439-0050
  • Serral, Gemma|||0000-0002-9968-5593
  • Valmayor, Sara|||0000-0003-4476-7898
  • Juárez Martínez, Olga|||0000-0001-5343-6295
  • López Medina, María José|||0000-0003-4402-2239
  • Ariza, Carles|||0000-0002-0101-1911
Childhood obesity has increased worldwide over the past four decades. This quasi-exper-imental study aimed to assess the effectiveness of a multicomponent and multilevel school-based intervention (POIBA) at 3 years of follow-up. The nutrition intervention focused on food groups, food pyramid, nutrients, portions, and balanced menus. In total, 3624 children participated in the study. Anthropometric measurements and information on food frequency and behavior, physical activity, and daily screen use were collected in the intervention (IG) and comparison group (CG). Positive unadjusted changes toward adherence to recommendations were found for water, meat, sweets, and fried potato consumption, proper breakfast, not having dinner in front of the TV, out-of-school physical activity, and daily screen use. Three scores were used to calculate the proportion of children making more than one change to improve healthy habits regarding physical activity (global Activity score), nutrition (global Nutrition score), and both (global score). Students exposed to the intervention had a significantly better global Activity score (16.2% IG vs. 11.9% CG; p = 0.012) and Global score (63.9% IG vs. 58.5% CG; p = 0.025). Intervention effects on obesity incidence at 3-year follow-up lost significance but maintained the positive trend. In conclusion, school-based interventions including a family component could be useful to address the childhood obesity problem.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines

  • Corujo, David|||0000-0001-7930-0935
  • Malinverni, Roberto|||0000-0002-0113-3417
  • Carrillo-Reixach, Juan|||0000-0002-8538-8264
  • Meers, Oliver|||0000-0001-9532-7767
  • Garcia-Jaraquemada, Arce|||0000-0001-6603-2003
  • Le Pannérer, Marguerite Marie|||0000-0002-5779-8805
  • Valero, Vanesa
  • Pérez, Ainoha
  • Del Río-Álvarez, Álvaro|||0000-0003-2338-0782
  • Royo, Laura|||0000-0001-5770-2001
  • Pérez-González, Beatriz|||0000-0001-9849-5176
  • Raurell Vila, Helena|||0000-0003-1196-836X
  • Acemel, Rafael D.|||0000-0003-4120-0140
  • Santos-Pereira, José M.|||0000-0003-3949-0644
  • Garrido-Pontnou, Marta|||0000-0002-7762-7085
  • Gómez-Skarmeta, José Luís|||0000-0001-5125-4332
  • Pasquali, Lorenzo|||0000-0003-2423-1826
  • Manyé, Josep|||0000-0002-3121-8016
  • Armengol, Carolina|||0000-0002-4690-4027
  • Buschbeck, Marcus|||0000-0002-3218-4567
MacroH2A histone variants have a function in gene regulation that is poorly understood at the molecular level. We report that macroH2A1.2 and macroH2A2 modulate the transcriptional ground state of cancer cells and how they respond to inflammatory cytokines. Removal of macroH2A1.2 and macroH2A2 in hepatoblastoma cells affects the contact frequency of promoters and distal enhancers coinciding with changes in enhancer activity or preceding them in response to the cytokine tumor necrosis factor alpha. Although macroH2As regulate genes in both directions, they globally facilitate the nuclear factor κB (NF-κB)-mediated response. In contrast, macroH2As suppress the response to the pro-inflammatory cytokine interferon gamma. MacroH2A2 has a stronger contribution to gene repression than macroH2A1.2. Taken together, our results suggest that macroH2As have a role in regulating the response of cancer cells to inflammatory signals on the level of chromatin structure. This is likely relevant for the interaction of cancer cells with immune cells of their microenvironment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ascitic fluid regulates the local innate immune response of patients with cirrhosis

  • Nieto Sáchica, Juan Camilo|||0000-0002-3400-1488
  • Perea, Lidia|||0000-0002-1624-0012
  • Soriano, German|||0000-0002-9267-6811
  • Zamora, Carlos|||0000-0003-2962-678X
  • Cantó, Elisabet|||0000-0002-1782-1855
  • Medina Dols, Aina
  • Poca Pastor, María Antonia|||0000-0002-3831-0536
  • Sánchez, Elisabet|||0000-0002-3280-9301
  • Roman, Eva|||0000-0001-9084-8555
  • Julià, Germà
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Gely, Cristina|||0000-0003-0144-4650
  • Alvarado-Tapias, Edilmar|||0000-0003-2036-6133
  • Guarner-Argente, Carlos|||0000-0002-8180-1488
  • Juárez Rubio, Cándido|||0000-0003-2235-9893
  • Vidal, Silvia|||0000-0002-3909-6682
Ascitic neutrophils from cirrhotic patients with spontaneous bacterial peritonitis (SBP) exhibit an impaired oxidative burst that could facilitate bacterial infection. However, the influence of the cell-free ascitic fluid of these patients on neutrophil function has not been investigated. To analyze this influence, we determined the ascitic levels of cytokines, resistin, and lactoferrin and their association with neutrophil function, disease severity score, and SBP resolution. We analyzed NETosis induction by microscopy and oxidative burst by the flow cytometry of healthy neutrophils cultured in ascitic fluid from cirrhotic patients with sterile ascites (SA) and with SBP before and after antibiotic treatment. Resistin, IL-6, IL-1 receptor antagonist, IL-1β, and lactoferrin levels were measured in ascitic fluids and supernatants of cultured neutrophils and PBMCs by ELISA. Upon stimulation, healthy neutrophils cultured in SBP ascitic fluid produced lower NETosis and oxidativeburst than those cultured in SA. Ascitic resistin levels were negatively correlated with NETosis, oxidative burst, and ascitic glucose levels; and positively correlated with the model for end-stage liver disease score. After an E. coli or TNF-α stimulus, neutrophils were the major resistin producers. Resistin indirectly reduced the oxidative burst of neutrophils and directly reduced the inflammatory phenotype of monocytes and TNF-α production. Bacterial-induced resistin production can down-regulate the inflammatory response of macrophages and neutrophil function in ascitic fluid. Consequently, this down-regulation may jeopardize the elimination of bacteria that translocate to ascitic fluid in patients with cirrhosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hierarchical Cluster Analysis Based on Clinical and Neuropsychological Symptoms Reveals Distinct Subgroups in Fibromyalgia, A Population-Based Cohort Study

  • Maurel, Sara
  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • Alegre Martín, José|||0000-0002-7582-7585
  • Castro-Marrero, Jesús|||0000-0002-2481-3052
Fibromyalgia (FM) is a condition characterized by musculoskeletal pain and multiple comorbidities. Our study aimed to identify four clusters of FM patients according to their core clinical symptoms and neuropsychological comorbidities to identify possible therapeutic targets in the condition. We performed a population-based cohort study on 251 adult FM patients referred to primary care according to the 2010 ACR case criteria. Patients were aggregated in clusters by a K-medians hierarchical cluster analysis based on physical and emotional symptoms and neuropsychological variables. Four different clusters were identified in the FM population. Global cluster analysis reported a four-cluster profile (cluster 1: pain, fatigue, poorer sleep quality, stiffness, anxiety/depression and disability at work; cluster 2: injustice, catastrophizing, positive affect and negative affect; cluster 3: mindfulness and acceptance; and cluster 4: surrender). The second analysis on clinical symptoms revealed three distinct subgroups (cluster 1: fatigue, poorer sleep quality, stiffness and difficulties at work; cluster 2: pain; and cluster 3: anxiety and depression). The third analysis of neuropsychological variables provided two opposed subgroups (cluster 1: those with high scores in surrender, injustice, catastrophizing and negative affect, and cluster 2: those with high scores in acceptance, positive affect and mindfulness). These empirical results support models that assume an interaction between neurobiological, psychological and social factors beyond the classical biomedical model. A detailed assessment of such risk and protective factors is critical to differentiate FM subtypes, allowing for further identification of their specific needs and designing tailored personalized therapeutic interventions.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome

  • García Castaño, Alejandro
  • Pérez de Nanclares, Gustavo
  • Madariaga, Leire
  • Aguirre, Mireia
  • Madrid Aris, Alvaro Domingo
  • Chocron de Benzaquen, Sara
  • Ariceta Iraola, Gema
Excreció; Genètica humana; Mutació, Excreción; Genética humana; Mutación, Excretion; Human genetics; Mutation, Introduction Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p.Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS. Methods Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses. Results Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype. Conclusion A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort, This study was supported by two grants (PI09/90888 and PI11/01412) from the FIS of the Instituto de Salud Carlos III, Madrid, Spain, the Department of Health of the Basque Government (2014111064), and the Department of Education of the Basque Government (IT795-13).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

  • Ruiz de Porras, Vicenç
  • Bystrup, Sara
  • Cabrero-de Las Heras, Sara
  • Musulén, Eva
  • Palomero, Luis
  • Henar Alonso, Maria
  • Arango Corro, Diego
  • Nieto Raya, Rocio
Colorectal cancer; Cyclin-dependent kinase 5 (Cdk5); Prognostic and predictive biomarker, Cáncer colorrectal; Quinasa dependiente de ciclina 5 (Cdk5); Biomarcador pronóstico y predictivo, Càncer colorectal; Quinasa dependent de ciclina 5 (CDK5); Biomarcador pronòstic i predictiu, In recent years, an increasing number of studies have shown that elevated expression of cyclin dependent kinase (Cdk5) contributes to the oncogenic initiation and progression of many types of cancers. In this study, we investigated the expression pattern of Cdk5 in colorectal cancer (CRC) cell lines and in a large number of tumor samples in order to evaluate its relevance in this pathogenesis and possible use as a prognostic marker. We found that Cdk5 is highly expressed and activated in CRC cell lines and that silencing of the kinase decreases their migration ability. In tumor tissues, Cdk5 is overexpressed compared to normal tissues due to a copy number gain. In patients with localized disease, we found that high Cdk5 levels correlate with poor prognosis, while in the metastatic setting, this was only the case for patients receiving an oxaliplatin-based treatment. When exploring the Cdk5 levels in the consensus molecular subtypes (CMS), we found the lowest levels in subtype 1, where high Cdk5 again was associated with a poorer prognosis. In conclusion, we confirm that Cdk5 is involved in CRC and disease progression and that it could serve as a prognostic and predictive biomarker in this disease., This work has been funded by the ISCIII grants from the Spanish Government, project numbers PI09/01334 and PI12/02228, and the Departament d’Innovació, Universitats i Empresa, Generalitat de Catalunya, project numbers 2014-SGR-1494, 2017-SGR-1705 and 2017-SGR-723. The group from Eva Martinez Balibrea is furthermore funded by the PIE16/00011 and the group from Diego Arango by the PI16/00540 and AC15/00066 grants.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM

  • Llauradó Cabot, Gemma
  • Cano, Albert
  • Albert, Lara
  • Ballesta, Silvia
  • Mazarico, Isabel
  • Luchtenberg, María F.
  • Simó Canonge, Rafael
Steno Type 1 Risk Engine (ST1RE); Arterial stiffness; Type 1 diabetes (T1DM), Motor de Risc Steno Tipus 1; Rigidesa arterial; Diabetis mellitus tipus 1 (DM1), Motor de Riesgo Steno Tipo 1; Rigidez arterial; Diabetes mellitus tipo 1 (DM1), OBJECTIVES: Currently used risk scores for type 2 diabetes mellitus (T2DM) clearly underestimate cardiovascular risk in type 1 diabetes (T1DM). Hence, there is a need to develop novel and specific risk-estimation tools for this population. We aimed to assess the relationship between the Steno Type 1 Risk Engine (ST1RE) and arterial stiffness (AS), and to identify potential cut-off points of interest in clinical practice. DESIGN AND METHODS: A total of 179 patients with T1DM (50.8% men, mean age 41.2±13.1 years), without established cardiovascular disease, were evaluated for clinical and anthropometric data (including classical cardiovascular risk factors), and AS measured by aortic pulse-wave velocity (aPWV). The ST1RE was used to estimate 10-year cardiovascular risk and patients were classified into 3 groups: low- (<10%; n = 105), moderate- (10-20%; n = 53) and high-risk (≥20%; n = 21). RESULTS: When compared with the low- and moderate-risk groups, patients in the high-risk group were older, had higher prevalence of hypertension, dyslipidemia and insulin-resistance, and had higher body-mass index and HbA1c. aPWV increased in parallel with estimated cardiovascular risk (6.4±1.0, 8.4±1.3 and 10.3±2.6m/s; p<0.001). As an evaluation of model performance, the C-statistic of aPWV was 0.914 (95% confidence interval [CI]:0.873-0.950) for predicting moderate/high-risk and 0.879 (95%CI:0.809-0.948) for high-risk, according to the ST1RE. The best cut-off points of aPWV were 7.3m/s (sensitivity:86%, specificity:83%) and 8.7m/s (sensitivity:76%, specificity:86%) for moderate/high- and high-risk, respectively. CONCLUSIONS: AS is highly correlated with the scores obtained from the ST1RE. We have identified two cut-off points of AS that can clearly discriminate moderate/high- and high-risk T1DM patients, which could be of great value in clinical practice., Financial support was provided through the Fondo de Investigacion Sanitaria (FIS) PI09/01360 (PI: JMCG), PI12/00954 (PI: JMCG) and PI15/00567 (PI: JMCG) as part of the National R+D+I (2008-2011) and was co-financed by the Instituto de Salud Carlos III - General Evaluation Branch (Spanish Ministry of Economy and Competitiveness) and the European Regional Development Fund (ERDF). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.